Professor Philip Johnson MD, FRCP
Professor in Translational Oncology Molecular & Clinical Cancer Medicine
- +44 (0)151 795 8410
- Work email Philip.Johnson@liverpool.ac.uk
Publications
Filter the publication list
Filter list by type
- Show all
- Journal article
- Conference paper
- Chapter
- Other
2024
Serologic Detection of Hepatocellular Carcinoma: Application of Machine Learning and Implications for Diagnostic Models. (Journal article)
Johnson, P. J., Bhatti, E., Toyoda, H., & He, S. (2024). Serologic Detection of Hepatocellular Carcinoma: Application of Machine Learning and Implications for Diagnostic Models.. JCO clinical cancer informatics, 8, e2300199. doi:10.1200/cci.23.00199Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma. (Journal article)
Toyoda, H., Kanneganti, M., Melendez-Torres, J., Parikh, N. D., Jalal, P. K., Piñero, F., . . . Johnson, P. J. (2024). Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22(1), 72-80.e4. doi:10.1016/j.cgh.2023.06.0262023
European' health care indicators and pancreatic cancer incidence and mortality: A mediation analysis of Eurostat data and Global Burden of Disease Study 2019. (Journal article)
Cucchetti, A., Johnson, P., Capurso, G., Crippa, S., Pacilio, C. A., Fabbri, C., . . . Ercolani, G. (2023). European' health care indicators and pancreatic cancer incidence and mortality: A mediation analysis of Eurostat data and Global Burden of Disease Study 2019.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 23(7), 829-835. doi:10.1016/j.pan.2023.09.001Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score (Journal article)
Truong, T. N., Pham, T. N. D., Hoang, L. B., Nguyen, V. T., Dao, H. V., Dao, D. V. B., . . . Dao, D. Y. (2023). Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score. BMC CANCER, 23(1). doi:10.1186/s12885-023-11167-9Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study (Journal article)
Hamill, V., Wong, S., Benselin, J., Krajden, M., Hayes, P. C., Mutimer, D., . . . Innes, H. (2023). Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study. BMJ-BRITISH MEDICAL JOURNAL, 382. doi:10.1136/bmj-2022-074001Exploration of the lack of systematic surveillance for hepatocellular carcinoma for patients with non-alcoholic fatty liver disease (Journal article)
Hydes, T., Blake, C. H., Kassab, M., Matthews, C., Kumar, V., Baggus, E., . . . Cross, T. (2023). Exploration of the lack of systematic surveillance for hepatocellular carcinoma for patients with non-alcoholic fatty liver disease. Journal of Hepatology, 78, S521-S522. doi:10.1016/s0168-8278(23)01278-3'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured? (Journal article)
Cucchetti, A., Elshaarawy, O., Han, G., Chong, C. C. N., Serra, C., O'Rourke, J. M., . . . Johnson, P. J. (2023). 'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?. BRITISH JOURNAL OF CANCER, 128(9), 1665-1671. doi:10.1038/s41416-023-02188-zTextbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma (Journal article)
Mosconi, C., O'Rourke, J., Kloeckner, R., Sturm, L., Golfieri, R., Celsa, C., . . . Cucchetti, A. (2023). Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 46(4), 449-459. doi:10.1007/s00270-023-03375-4Predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review (Journal article)
Vogel, A., Kelley, R. K., Johnson, P., Merle, P., Yau, T., Kudo, M., . . . Rimassa, L. (2023). Predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review. LIVER CANCER, 12(4), 372-391. doi:10.1159/000529173Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease (Journal article)
Hydes, T. J., Cuthbertson, D. J., Palmer, D. H., Elshaarawy, O., Johnson, P. J., Fernando, R., & Cross, T. J. (2023). Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. HEPATOMA RESEARCH, 9. doi:10.20517/2394-5079.2022.972022
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify (Journal article)
Johnson, P. J., Innes, H., Hughes, D. M., Kalyuzhnyy, A., Kumada, T., & Toyoda, H. (2022). Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify. BRITISH JOURNAL OF CANCER, 127(7), 1263-1269. doi:10.1038/s41416-022-01851-1Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma (Journal article)
Johnson, P., Zhou, Q., Dao, D. Y., & Lo, Y. M. D. (2022). Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 19(10), 670-681. doi:10.1038/s41575-022-00620-yThe ALBI score: From liver function in patients with HCC to a general measure of liver function (Journal article)
Toyoda, H., & Johnson, P. J. (2022). The ALBI score: From liver function in patients with HCC to a general measure of liver function. JHEP REPORTS, 4(10). doi:10.1016/j.jhepr.2022.100557Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication? (Journal article)
Innes, H., Hamill, V., McDonald, S. A., Hayes, P. C., Johnson, P., Dillon, J. F., . . . Hutchinson, S. J. (2022). Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?. AMERICAN JOURNAL OF GASTROENTEROLOGY, 117(9), 1454-1461. doi:10.14309/ajg.0000000000001879LACK OF NAFLD-RELATED HEPATOCELLULAR CARCINOMA SURVEILLANCE MAY EXPLAIN MORE ADVANCED STAGE AT DIAGNOSIS AND WORSE MEDIAN SURVIVAL (Conference Paper)
Hydes, T., Matthews, C., Kumar, V., Kassab, M., Blake, C. H., Baggus, E., . . . Cross, T. (2022). LACK OF NAFLD-RELATED HEPATOCELLULAR CARCINOMA SURVEILLANCE MAY EXPLAIN MORE ADVANCED STAGE AT DIAGNOSIS AND WORSE MEDIAN SURVIVAL. In GUT Vol. 71 (pp. A46-A47). doi:10.1136/gutjnl-2022-BASL.72Improved survival of viral hepatocellular carcinoma but non-viral hepatocellular carcinoma from 2000 to 2020: A multicenter cohort study of 6007 patients from high-volume academic centers in Japan (Journal article)
Toyoda, H., Kariyama, K., Hiraoka, A., Tsuji, K., Ishikawa, T., Hatanaka, T., . . . Johnson, P. J. (2022). Improved survival of viral hepatocellular carcinoma but non-viral hepatocellular carcinoma from 2000 to 2020: A multicenter cohort study of 6007 patients from high-volume academic centers in Japan. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 56(4), 694-701. doi:10.1111/apt.17088Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma (Journal article)
Kudo, M., Ueshima, K., Ikeda, M., Torimura, T., Tanabe, N., Aikata, H., . . . Arai, Y. (2022). Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma. LIVER CANCER, 11(4), 354-367. doi:10.1159/000522547Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma comment (Journal article)
Johnson, P. J., Pinato, D. J., Kalyuzhnyy, A., & Toyoda, H. (2022). Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma comment. JOURNAL OF CLINICAL ONCOLOGY, 40(19), 2078-+. doi:10.1200/JCO.21.02373Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis (Journal article)
Mishra, G., Majeed, A., Dev, A., Eslick, G. D., Pinato, D. J., Izumoto, H., . . . Roberts, S. K. (2022). Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis. JOURNAL OF GASTROINTESTINAL CANCER. doi:10.1007/s12029-022-00832-0Sorafenib is associated with reduced tumour growth rate and liver function deterioration in HCV-induced hepatocellular carcinoma (Journal article)
Kolamunnage-Dona, R., & Johnson, P. (2022). Sorafenib is associated with reduced tumour growth rate and liver function deterioration in HCV-induced hepatocellular carcinoma. Journal of Hepatology.Obituary for Dr. Ian G. McFarlane and Dr. Barbara McFarlane Obituary Obituary (Journal article)
Johnson, P. J. (2022). Obituary for Dr. Ian G. McFarlane and Dr. Barbara McFarlane Obituary Obituary. JOURNAL OF HEPATOLOGY, 77(2), 277. doi:10.1016/j.jhep.2022.04.017The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival (Journal article)
Hydes, T. J., Cuthbertson, D. J., Graef, S., Berhane, S., Teng, M., Skowronska, A., . . . Johnson, P. J. (2022). The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival. Clinical Therapeutics. doi:10.1016/j.clinthera.2021.12.011Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making (Journal article)
Innes, H., Johnson, P., McDonald, S. A., Hamill, V., Yeung, A., Dillon, J. F., . . . Hutchinson, S. J. (2022). Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making. Gastro Hep Advances, 1(2), 129-136. doi:10.1016/j.gastha.2021.11.008The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality (Journal article)
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., . . . Manns, M. P. (2022). The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. LANCET, 399(10319), 61-116. doi:10.1016/S0140-6736(21)01701-32021
Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study (Journal article)
Zhong, J. -H., Xing, B. -C., Zhang, W. -G., Chan, A. W. -H., Chong, C. C. N., Serenari, M., . . . Xiang, B. -D. (2022). Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study. BRITISH JOURNAL OF SURGERY, 109(1), 71-78. doi:10.1093/bjs/znab340Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection (Journal article)
Innes, H., Jepsen, P., McDonald, S., Dillon, J., Hamill, V., Yeung, A., . . . Guha, I. N. (2021). Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection. JHEP REPORTS, 3(6). doi:10.1016/j.jhepr.2021.100384Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment (Journal article)
Cucchetti, A., Gramenzi, A., Johnson, P., Giannini, E. G., Tovoli, F., Rapaccini, G. L., . . . Romagnoli, V. (2021). Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. European Journal of Cancer, 158, 133-143. doi:10.1016/j.ejca.2021.09.018Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA (Journal article)
Fateen, W., Johnson, P. J., Wood, H. M., Zhang, H., He, S., El-Meteini, M., . . . Quirke, P. (2021). Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA. JOURNAL OF PATHOLOGY, 255(1), 30-40. doi:10.1002/path.5734Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis (Journal article)
Edeline, J., Lamarca, A., McNamara, M. G., Jacobs, T., Hubner, R. A., Palmer, D., . . . Valle, J. W. (2021). Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis. CANCER TREATMENT REVIEWS, 99. doi:10.1016/j.ctrv.2021.102258The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study (Journal article)
Johnson, P. J., Dhanaraj, S., Berhane, S., Bonnett, L., & Ma, Y. T. (2021). The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. BRITISH JOURNAL OF CANCER, 125(5), 714-716. doi:10.1038/s41416-021-01445-3GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients (Journal article)
Schotten, C., Ostertag, B., Sowa, J. -P., Manka, P., Bechmann, L. P., Hilgard, G., . . . Best, J. (n.d.). GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients. Pharmaceuticals, 14(8), 735. doi:10.3390/ph14080735Systematic review and pooled analysis of locoregional therapies in patients with intrahepatic cholangiocarcinoma (Conference Paper)
Edeline, J., Lamarca, A., McNamara, M., Jacobs, T., Hubner, R., Palmer, D., . . . Valle, J. (2021). Systematic review and pooled analysis of locoregional therapies in patients with intrahepatic cholangiocarcinoma. In ANNALS OF ONCOLOGY Vol. 32 (pp. S177). doi:10.1016/j.annonc.2021.05.283Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus (Journal article)
Kumada, T., Toyoda, H., Yasuda, S., Tada, T., Tanaka, J., Chayama, K., . . . Irving, W. L. (2021). Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus. INFECTIOUS DISEASES AND THERAPY, 10(2), 1001-1013. doi:10.1007/s40121-021-00441-7In search of an evidence base for HCC surveillance: Purity or pragmatism? (Journal article)
Johnson, P. J. (2021). In search of an evidence base for HCC surveillance: Purity or pragmatism?. JOURNAL OF HEPATOLOGY, 74(5), 1025-1027. doi:10.1016/j.jhep.2021.02.018Impact Of Direct Acting Antiviral Agents On Liver Function In Patients With Chronic Hepatitis C Virus Infection. (Journal article)
Johnson, P. J., Berhane, S., Walker, A. J., Gordon, F. H., Ryder, S. D., McPherson, S., . . . Irving, W. L. (2021). Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection. JOURNAL OF VIRAL HEPATITIS, 28(1), 168-176. doi:10.1111/jvh.134082020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis (Journal article)
Fan, R., Papatheodoridis, G., Sun, J., Innes, H., Toyoda, H., Xie, Q., . . . Hou, J. (2020). aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. JOURNAL OF HEPATOLOGY, 73(6), 1368-1378. doi:10.1016/j.jhep.2020.07.025AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy (Journal article)
Johnson, P., Berhane, S., de Groot, E., Toyoda, H., Tada, T., Kumada, T., . . . Hughes, D. M. (2020). AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy. Journal of Hepatology, 73, S387-S388. doi:10.1016/s0168-8278(20)31265-4Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma (Journal article)
Johnson, P., Berhane, S., & Kolamunnage-Dona, R. (2020). Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma. Journal of Hepatology, 73, S388. doi:10.1016/s0168-8278(20)31267-8The prognostic and diagnostic significance of the neutrophil to lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study (Journal article)
Johnson, P., Dhanaraj, S., Ma, Y. T., Bonnett, L., & Berhane, S. (2020). The prognostic and diagnostic significance of the neutrophil to lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. Journal of Hepatology, 73, S388. doi:10.1016/s0168-8278(20)31266-6Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach (Journal article)
Han, G., Berhane, S., Toyoda, H., Bettinger, D., Elshaarawy, O., Chan, A. W. H., . . . Johnson, P. J. (2020). Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach. Hepatology (Baltimore, Md.), 72(01), 198-212. doi:10.1002/hep.31022Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. (Journal article)
Kudo, M., Ueshima, K., Ikeda, M., Torimura, T., Tanabe, N., Aikata, H., . . . TACTICS study group. (2020). Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.. Gut, 69(8), 1492-1501. doi:10.1136/gutjnl-2019-318934Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI study (Journal article)
Kumada, T., Toyoda, H., Yasuda, S., Tada, T., Ogawa, S., Takeshima, K., . . . Johnson, P. J. (2020). Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 52(2), 359-370. doi:10.1111/apt.15825Validation and refinement of PROSASH model using the neutrophil‐to‐lymphocyte ratio in patients with HCC receiving sorafenib (Journal article)
Casadei‐Gardini, A., Cabibbo, G., Dadduzio, V., Orsi, G., Vukotic, R., Rizzato, M. D., . . . Cucchetti, A. (2020). Validation and refinement of PROSASH model using the neutrophil‐to‐lymphocyte ratio in patients with HCC receiving sorafenib. Liver Cancer International, 1(1), 6-11. doi:10.1002/lci2.12Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma (Journal article)
Hughes, D. M., Berhane, S., Emily de Groot, C. A., Toyoda, H., Tada, T., Kumada, T., . . . Johnson, P. (2020). Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2020.04.084Response to: Prognostication of HCC patients under sorafenib is not always possible (Journal article)
Labeur, T. A., Berhane, S., & Johnson, P. J. (2020). Response to: Prognostication of HCC patients under sorafenib is not always possible. LIVER INTERNATIONAL, 40(5), 1243-1244. doi:10.1111/liv.14335GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis (Journal article)
Best, J., Bechmann, L. P., Sowa, J. -P., Sydor, S., Dechene, A., Pflanz, K., . . . Canbay, A. (2020). GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 18(3), 728-+. doi:10.1016/j.cgh.2019.11.012Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib (Journal article)
Labeur, T. A., Berhane, S., Edeline, J., Blanc, J. -F., Bettinger, D., Meyer, T., . . . Johnson, P. J. (2020). Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib. LIVER INTERNATIONAL, 40(1), 215-228. doi:10.1111/liv.142702019
The chances of hepatic resection curing hepatocellular carcinoma. (Journal article)
Cucchetti, A., Zhong, J., Berhane, S., Toyoda, H., Shi, K., Tada, T., . . . Johnson, P. J. (2019). The chances of hepatic resection curing hepatocellular carcinoma.. Journal of hepatology. doi:10.1016/j.jhep.2019.11.016Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials (Journal article)
Cabibbo, G., Cucchetti, A., Cammà, C., Casadei-Gardini, A., Celsa, C., Emanuele Maria Rizzo, G., . . . Ercolani, G. (2019). Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials. Future Oncology, 15(29), 3411-3422. doi:10.2217/fon-2019-0287Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation (Journal article)
Guha, I. N., Harris, R., Berhane, S., Dillon, A., Coffey, L., James, M. W., . . . Johnson, P. J. (2019). Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(11), 2330-+. doi:10.1016/j.cgh.2019.01.042The Epidemiology of Hepatocellular Carcinoma (Chapter)
Johnson, P. (2019). The Epidemiology of Hepatocellular Carcinoma. In Liver Cancers (pp. 3-11). Springer International Publishing. doi:10.1007/978-3-319-92216-4_1A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma (Journal article)
Amoros, R., King, R., Toyoda, H., Kumada, T., Johnson, P. J., & Bird, T. G. (2019). A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma. Metron, 77(2), 67-86. doi:10.1007/s40300-019-00151-8Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment (Journal article)
Berhane, S., Fox, R., Garcia-Finana, M., Cucchetti, A., & Johnson, P. (2019). Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment. British Journal of Cancer, 121, 117-124. doi:10.1038/s41416-019-0488-4Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study (Journal article)
Ueshima, K., Nishida, N., Hagiwara, S., Aoki, T., Minami, T., Chishina, H., . . . Kudo, M. (2019). Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study. CANCERS, 11(7). doi:10.3390/cancers11070952Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score (Journal article)
Dupre, A., Berhane, S., Chan, A. W. H., Rivoire, M., Chong, C. C. N., Lai, P. B. S., . . . Johnson, P. J. (2019). Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score. EJSO, 45(6), 999-1004. doi:10.1016/j.ejso.2019.02.022Trial endpoints for systemic therapy in patients with hepatocellular carcinoma (Journal article)
Meyer, T., & Johnson, P. (2019). Trial endpoints for systemic therapy in patients with hepatocellular carcinoma. JOURNAL OF HEPATOLOGY, 70(6), 1060-1061. doi:10.1016/j.jhep.2019.03.001Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy (Journal article)
Cucchetti, A., Russolillo, N., Johnson, P., Tarchi, P., Ferrero, A., Cucchi, M., . . . Ercolani, G. (2019). Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy. BJS OPEN, 3(2), 186-194. doi:10.1002/bjs5.100Reply to: Correspondence concerning "Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection" (Journal article)
Chan, A. W. H., Berhane, S., Cucchetti, A., & Johnson, P. J. (2019). Reply to: Correspondence concerning "Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection". JOURNAL OF HEPATOLOGY, 70(3), 573-574. doi:10.1016/j.jhep.2018.11.026The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study (Journal article)
Toyoda, H., Kumada, T., Tada, T., Mizuno, K., Sone, Y., Akita, T., . . . Johnson, P. J. (2019). The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study. Liver International, 39(3), 448-454. doi:10.1111/liv.13987Very Early Diagnosis of Hepatocellular Carcinoma: Serological Approaches (Conference Paper)
Johnson, P. J. (2019). Very Early Diagnosis of Hepatocellular Carcinoma: Serological Approaches. In JOURNAL OF PATHOLOGY Vol. 248 (pp. S3). Retrieved from https://www.webofscience.com/2018
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. (Journal article)
Chan, A. W. H., Zhong, J., Berhane, S., Toyoda, H., Cucchetti, A., Shi, K., . . . Johnson, P. J. (2018). Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.. Journal of hepatology, 69(6), 1284-1293. doi:10.1016/j.jhep.2018.08.027Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma (Journal article)
Pinna, A. D., Yang, T., Mazzaferro, V., De Carlis, L., Zhou, J., Roayaie, S., . . . Cucchetti,, A. (2018). Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma. Annals of Surgery, 268(5), 868-875. Retrieved from https://journals.lww.com/A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection (Journal article)
Cai, B. -B., Shi, K. -Q., Li, P., Chen, B. -C., Shi, L., Johnson, P. J., . . . Zhou, M. -T. (2018). A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection. CLINICA CHIMICA ACTA, 485, 187-194. doi:10.1016/j.cca.2018.06.020Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma (Journal article)
Chong, C. C. -N., Chan, A. W. -H., Wong, J., Chu, C. -M., Chan, S. L., Lee, K. -F., . . . Lai, P. B. -S. (2018). Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 16(3), 163-170. doi:10.1016/j.surge.2017.07.003Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection (Journal article)
Chong, C. C. N., Lee, K. -F., Chu, C. -M., Chan, A. W. H., Wong, J., Chan, S. L., . . . Lai, P. B. S. (2018). Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection. HPB, 20(6), 546-554. doi:10.1016/j.hpb.2017.12.001Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial (Journal article)
Kudo, M., Ueshima, K., Yokosuka, O., Ogasawara, S., Obi, S., Izumi, N., . . . SILIUS Study Group. (2018). Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 3(6), 424-432. doi:10.1016/S2468-1253(18)30078-5A statistical model for survival risk prediction in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment (Conference Paper)
Berhane, S., Fox, R., Chan, S. L., Yau, T., & Johnson, P. (2018). A statistical model for survival risk prediction in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment. In JOURNAL OF HEPATOLOGY Vol. 68 (pp. S197-S198). doi:10.1016/S0168-8278(18)30607-XImpact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection (Conference Paper)
Toyoda, H., Berhane, S., de Groot, E., Tada, T., Kumada, T., Irving, W., & Johnson, P. (2018). Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection. In JOURNAL OF HEPATOLOGY Vol. 68 (pp. S530). doi:10.1016/S0168-8278(18)31312-6Serological diagnosis of early HCC in NASH: A German multicenter study (Conference Paper)
Best, J., Bechmann, L., Dechene, A., Pflanz, K., Bedreli, S., Schotten, C., . . . Canbay, A. (2018). Serological diagnosis of early HCC in NASH: A German multicenter study. In JOURNAL OF HEPATOLOGY Vol. 68 (pp. S421-S422). doi:10.1016/S0168-8278(18)31083-3Predictors of sorafenib benefit in patients with hepatocellular carcinoma (Journal article)
Jackson, R., Psarelli, E., Berhane, S., & Johnson, P. J. (2018). Predictors of sorafenib benefit in patients with hepatocellular carcinoma. Journal of Hepatology, 68(3), 619-620. doi:10.1016/j.jhep.2017.09.0282017
Risk estimation for biliary tract cancer: Development and validation of a prognostic score (Journal article)
Schweitzer, N., Fischer, M., Kirstein, M. M., Berhane, S., Kottas, M., Sinn, M., . . . Vogel, A. (2017). Risk estimation for biliary tract cancer: Development and validation of a prognostic score. LIVER INTERNATIONAL, 37(12), 1852-1860. doi:10.1111/liv.13517Reply to 'Comment on 'Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion'' (Journal article)
Waked, I., & Johnson, P. J. (2017). Reply to 'Comment on 'Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion''. BRITISH JOURNAL OF CANCER, 117(10). doi:10.1038/bjc.2017.241Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey. (Journal article)
Toyoda, H., Tada, T., Johnson, P. J., Izumi, N., Kadoya, M., Kaneko, S., . . . Kudo, M. (2017). Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey. JOURNAL OF GASTROENTEROLOGY, 52(10), 1112-1121. doi:10.1007/s00535-017-1321-6Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial (Journal article)
Meyer, T., Fox, R., Ma, Y. T., Ross, P. J., James, M. W., Sturgess, R., . . . Palmer, D. H. (2017). Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2(8), 565-575. doi:10.1016/S2468-1253(17)30156-5Assessment of Liver Function: Focus on the ALBI Score (Chapter)
Johnson, P. J., Khan, H., & Berhane, S. (2017). Assessment of Liver Function: Focus on the ALBI Score. In Radiation Therapy for Liver Tumors (pp. 31-38). Springer International Publishing. doi:10.1007/978-3-319-54531-8_3Reply to N. Personeni et al (Journal article)
Jackson, R., Psarelli, E., & Johnson, P. J. (2017). Reply to N. Personeni et al. Journal of Clinical Oncology, 35(19), 2214. doi:10.1200/JCO.2017.72.9293The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma (Journal article)
Johnson, P. J. (2017). The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 15(6), 452-454. Retrieved from https://www.webofscience.com/Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit. (Journal article)
King, J., Palmer, D. H., Johnson, P., Ross, P., Hubner, R. A., Sumpter, K., . . . Meyer, T. (2017). Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit.. Clinical oncology (Royal College of Radiologists (Great Britain)), 29(4), 256-262. doi:10.1016/j.clon.2016.11.012The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma. (Journal article)
Johnson, P. J. (2017). The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma.. Gastroenterology & hepatology, 13(4), 231-233.Ultrasound surveillance for hepatocellular carcinoma: service evaluation of a radiology-led recall system in a tertiary-referral centre for liver diseases in the UK (Journal article)
Farrell, C., Halpen, A., Cross, T. J. S., Richardson, P. D., Johnson, P., & Joekes, E. C. (2017). Ultrasound surveillance for hepatocellular carcinoma: service evaluation of a radiology-led recall system in a tertiary-referral centre for liver diseases in the UK. CLINICAL RADIOLOGY, 72(4). doi:10.1016/j.crad.2016.10.019Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials (Journal article)
Jackson, R., Psarelli, E. E., Berhane, S., Khan, H., & Johnson, P. J. (2017). Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials. Journal of Clinical Oncology, 35(6), 622-628. doi:10.1200/JCO.2016.69.5197Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance (Journal article)
Johnson, P., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Fox, R., . . . Kumada, T. (2017). Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance. British Journal of Cancer, 116, 441-447. doi:10.1038/bjc.2016.422Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion (Journal article)
Waked, I., Berhane, S., Toyoda, H., Chan, S. L., Stern, N., Palmer, D., . . . Johnson, P. J. (2017). Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion. BRITISH JOURNAL OF CANCER, 116(4), 448-454. doi:10.1038/bjc.2016.423Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: A meta-analysis of randomised phase III trials (Journal article)
Johnson, P. J., Jackson, R., Berhane, S., & Psarelli, E. (2017). Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: A meta-analysis of randomised phase III trials. Journal of Clinical Oncology. doi:10.1200/JCO.2016.69.5197Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma (Journal article)
Chan, A. W. H., Chong, C. C. N., Mo, F. K. F., Wong, J., Yeo, W., Johnson, P. J., . . . Chan, S. L. (2017). Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32(1), 221-228. doi:10.1111/jgh.13457Liver function as measured by albumin-bilirubin score within decompensated patients receiving direct acting antiviral therapy within the Expanded Access Programme (Conference Paper)
Walker, A. J., Johnson, P. J., & Irving, W. L. (2017). Liver function as measured by albumin-bilirubin score within decompensated patients receiving direct acting antiviral therapy within the Expanded Access Programme. In JOURNAL OF HEPATOLOGY Vol. 66 (pp. S746-S747). doi:10.1016/S0168-8278(17)31986-4Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study (Conference Paper)
Broadhurst, P., Toyoda, H., Kumada, T., Schweitzer, N., Vogel, A., Benckert, J., . . . Johnson, P. (2017). Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study. In JOURNAL OF HEPATOLOGY Vol. 66 (pp. S620-S621). doi:10.1016/S0168-8278(17)31684-7Serial changes in serum biomarkers (GALAD model) prior to detection of HCC by ultrasound surveillance; application of statistical process control methodology (Conference Paper)
Berhane, S., Johnson, P. J., Tada, T., Toyoda, H., Fox, R., Cox, T., & Kumada, T. (2017). Serial changes in serum biomarkers (GALAD model) prior to detection of HCC by ultrasound surveillance; application of statistical process control methodology. In JOURNAL OF HEPATOLOGY Vol. 66 (pp. S628). doi:10.1016/S0168-8278(17)31703-8Serum biomarker ('GALAD') response after resection of hepatocellular carcinoma: impact of tumour recurrence (Conference Paper)
Johnson, P. J., Berhane, S., Tada, T., Toyoda, H., & Kumada, T. (2017). Serum biomarker ('GALAD') response after resection of hepatocellular carcinoma: impact of tumour recurrence. In JOURNAL OF HEPATOLOGY Vol. 66 (pp. S621). doi:10.1016/S0168-8278(17)31685-92016
Protein Biomarkers in the Management of Hepatocellular Carcinoma: Novel Combinatory Approaches (Chapter)
Johnson, P., & Berhane, S. (2016). Protein Biomarkers in the Management of Hepatocellular Carcinoma: Novel Combinatory Approaches. In HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND TREATMENT, 3RD EDITION (pp. 331-338). doi:10.1007/978-3-319-34214-6_21A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma (Journal article)
Edeline, J., Blanc, J. -F., Johnson, P., Campillo-Gimenez, B., Ross, P., Ma, Y. T., . . . Meyer, T. (2016). A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 36(12), 1821-1828. doi:10.1111/liv.13170Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma (Journal article)
Chan, A. W. H., Chong, C. C. N., Mo, F. K. F., Wong, J., Yeo, W., Johnson, P. J., . . . Chan, S. L. (2016). Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31(10), 1766-1772. doi:10.1111/jgh.13339The GALAD serological model may permit earlier diagnosis of hepatocellular carcinoma in a screened cirrhotic population: a re-analysis of a prospective trial (Conference Paper)
Johnson, P. J., de Groot, E., Yamada, H., & Berhane, S. (2016). The GALAD serological model may permit earlier diagnosis of hepatocellular carcinoma in a screened cirrhotic population: a re-analysis of a prospective trial. In HEPATOLOGY Vol. 64 (pp. 644A). Retrieved from https://www.webofscience.com/Reply to: Comment on: 'Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade' (Journal article)
Johnson, P., Lai, P. B. S., & Toyoda, H. (2016). Reply to: Comment on: 'Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'. BRITISH JOURNAL OF CANCER, 115(5), E6. doi:10.1038/bjc.2016.197Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma (Journal article)
Chan, A. W. H., Kumada, T., Toyoda, H., Tada, T., Chong, C. C. N., Mo, F. K. F., . . . Chan, S. L. (2016). Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31(7), 1300-1306. doi:10.1111/jgh.13291Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients (Journal article)
Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., . . . Johnson, P. (2016). Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 14(6), 875-+. doi:10.1016/j.cgh.2015.12.042TACE 2: A randomized placebo-controlled, double blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC) Background (Conference Paper)
Meyer, T., Fox, R., Ma, Y. T., Ross, P. J., James, M., Strugess, R., . . . Palmer, D. H. (2016). TACE 2: A randomized placebo-controlled, double blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC) Background. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. doi:10.1200/JCO.2016.34.15_suppl.4018Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade (Journal article)
Toyoda, H., Lai, P. B. S., O'Beirne, J., Chong, C. C., Berhane, S., Reeves, H., . . . Johnson, P. J. (2016). Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. BRITISH JOURNAL OF CANCER, 114(7), 744-750. doi:10.1038/bjc.2016.33IDENTIFICATION OF ADVANCED FIBROSIS IN HEPATITIS C PATIENTS FOLLOWING SUSTAINED VIROLOGIC RESPONSE: A NEW PREDICTIVE MODEL (Conference Paper)
Berhane, S., Tachi, Y., Tada, T., Johnson, P., Kumada, T., & Toyoda, H. (2016). IDENTIFICATION OF ADVANCED FIBROSIS IN HEPATITIS C PATIENTS FOLLOWING SUSTAINED VIROLOGIC RESPONSE: A NEW PREDICTIVE MODEL. In JOURNAL OF HEPATOLOGY Vol. 64 (pp. S738-S739). doi:10.1016/S0168-8278(16)01435-5IMPACT OF AETIOLOGY ON SURVIVAL AFTER SORAFENIB TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS OF THREE LARGE RANDOMISED TRIALS (Journal article)
Johnson, P. J., Jackson, R., Psarelli, E. -E., Khan, H., & Berhane, S. (2016). IMPACT OF AETIOLOGY ON SURVIVAL AFTER SORAFENIB TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS OF THREE LARGE RANDOMISED TRIALS. JOURNAL OF HEPATOLOGY, 64, S222-S223. doi:10.1016/S0168-8278(16)00197-5LONG-TERM IMPACT OF RESPONSE TO INTERFERON-BASED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS IN RELATION TO LIVER FUNCTION, SURVIVAL AND CAUSE OF DEATH (Conference Paper)
Johnson, P., de Groot, E., Berhane, S., Tada, T., Kumada, T., & Toyoda, H. (2016). LONG-TERM IMPACT OF RESPONSE TO INTERFERON-BASED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS IN RELATION TO LIVER FUNCTION, SURVIVAL AND CAUSE OF DEATH. In JOURNAL OF HEPATOLOGY Vol. 64 (pp. S811-S812). doi:10.1016/S0168-8278(16)01585-3Long-term impact of response to interferon-based therapy in patients with chronic HCV in relation to liver function, survival and cause of death (Conference Paper)
Johnson, P. J., de Groot, E., Berhane, S., Tada, T., Kumada, T., & Toyoda, H. (2016). Long-term impact of response to interferon-based therapy in patients with chronic HCV in relation to liver function, survival and cause of death. In HEPATOLOGY Vol. 64 (pp. 444A). Retrieved from https://www.webofscience.com/2015
Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma (Journal article)
Chan, S. L., Mo, F., Johnson, P., Li, L., Tang, N., Loong, H., . . . Yeo, W. (2015). Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30(10), 1529-1535. doi:10.1111/jgh.13005Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinoma (Journal article)
Palmer, D. H., & Johnson, P. J. (2015). Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinoma. CANCER AND METASTASIS REVIEWS, 34(3), 497-509. doi:10.1007/s10555-015-9580-2Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. (Journal article)
Park, J. -W., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P. -J., . . . Sherman, M. (2015). Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.. Liver international : official journal of the International Association for the Study of the Liver, 35(9), 2155-2166. doi:10.1111/liv.12818Impact of Cytomegalovirus on Long-term Mortality and Cancer Risk After Organ Transplantation (Journal article)
Desai, R., Collett, D., Watson, C. J. E., Johnson, P. J., Moss, P., & Neuberger, J. (2015). Impact of Cytomegalovirus on Long-term Mortality and Cancer Risk After Organ Transplantation. TRANSPLANTATION, 99(9), 1989-1994. doi:10.1097/TP.0000000000000641Integration of Albumin-Bilirubin (ALBI) score into current tumour staging system for hepatocellular carcinoma (HCC) (Conference Paper)
Chan, S. L., To, K. F., Mo, F., Chong, C. C. N., Yeo, W., Johnson, P., . . . Chan, A. W. H. (2015). Integration of Albumin-Bilirubin (ALBI) score into current tumour staging system for hepatocellular carcinoma (HCC). In EUROPEAN JOURNAL OF CANCER Vol. 51 (pp. S414). doi:10.1016/S0959-8049(16)31160-1The Role of hepatic resection in the treatment of hepatocellular cancer (Journal article)
Roayaie, S., Jibara, G., Tabrizian, P., Park, J. -W., Yang, J., Yan, L., . . . Sherman, M. (2015). The Role of hepatic resection in the treatment of hepatocellular cancer. Hepatology, 62(2), 440-451. doi:10.1002/hep.27745Optimisation of pharmacy content in clinical cancer research protocols: Experience of the United Kingdom Chemotherapy and Pharmacy Advisory Service (Journal article)
Debruyne, P. R., Johnson, P. J., Pottel, L., Daniels, S., Greer, R., Hodgkinson, E., . . . Harvey, S. (2015). Optimisation of pharmacy content in clinical cancer research protocols: Experience of the United Kingdom Chemotherapy and Pharmacy Advisory Service. CLINICAL TRIALS, 12(3), 257-264. doi:10.1177/1740774515569610ALBI SCORE PREDICTS SURVIVAL IN PATIENTS WITH BCLC 0/A STAGE HEPATOCELLULAR CARCINOMA (HCC) INDEPENDENTLY OF CHILD PUGH (CP) SCORE AND TREATMENT ALLOCATION (Conference Paper)
Onali, S., Marshall, A., Sharma, D., O'Donoghue, P., Dannhorn, E., Johnson, P., & O'Beirne, J. (2015). ALBI SCORE PREDICTS SURVIVAL IN PATIENTS WITH BCLC 0/A STAGE HEPATOCELLULAR CARCINOMA (HCC) INDEPENDENTLY OF CHILD PUGH (CP) SCORE AND TREATMENT ALLOCATION. In GUT Vol. 64 (pp. A459-A460). doi:10.1136/gutjnl-2015-309861.1006ALBI SCORE PREDICTS SURVIVAL INDEPENDENTLY OF HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND INDOCYANINE GREEN (ICG) CLEARANCE IN HCC PATIENTS UNDERGOING RESECTION (Conference Paper)
Onali, S., Marshall, A., Sharma, D., O'Donoghue, P., Dannhorn, E., Johnson, P., & O'Beirne, J. (2015). ALBI SCORE PREDICTS SURVIVAL INDEPENDENTLY OF HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND INDOCYANINE GREEN (ICG) CLEARANCE IN HCC PATIENTS UNDERGOING RESECTION. In GUT Vol. 64 (pp. A460-A461). doi:10.1136/gutjnl-2015-309861.1008URINARY VOLATILE ORGANIC COMPOUNDS AS A BIOMARKER FOR HEPATOCELLULAR CARCINOMA (HCC) (Conference Paper)
Bond, A., Aggio, R., Johnson, P., Berhane, S., & Probert, C. (2015). URINARY VOLATILE ORGANIC COMPOUNDS AS A BIOMARKER FOR HEPATOCELLULAR CARCINOMA (HCC). In GUT Vol. 64 (pp. A462). doi:10.1136/gutjnl-2015-309861.1011THE 'GALAD SCORE' FOR SEROLOGICAL DETECTION OF HEPATOCELLULAR CARCINOMA: INTERNATIONAL VALIDATION AND ASSESSMENT OF THE INFLUENCE OF TUMOUR SIZE AND AETIOLOGY ON MODEL UTILITY (Conference Paper)
Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., . . . Johnson, P. (2015). THE 'GALAD SCORE' FOR SEROLOGICAL DETECTION OF HEPATOCELLULAR CARCINOMA: INTERNATIONAL VALIDATION AND ASSESSMENT OF THE INFLUENCE OF TUMOUR SIZE AND AETIOLOGY ON MODEL UTILITY. In JOURNAL OF HEPATOLOGY Vol. 62 (pp. S434). doi:10.1016/S0168-8278(15)30546-8Are the current EASL/AASLD guidelines for resection of hepatocellular carcinoma optimal? Analysis of the BRIDGE study (Journal article)
Johnson, P. J., Roayaie, S., Jibara, G., Tabrizian, P., Park, J. -W., Yang, J., . . . Sherman, M. (2015). Are the current EASL/AASLD guidelines for resection of hepatocellular carcinoma optimal? Analysis of the BRIDGE study. Hepatology. doi:10.1002/hep.27745Assessment of liver function in patients with hepatocellular caicnoma: a new evidence-based approach - The ALBI Grade (Journal article)
Johnson, P., & Berhane, S. (2015). Assessment of liver function in patients with hepatocellular caicnoma: a new evidence-based approach - The ALBI Grade. Journal of Clinical Oncology, 33(6), 550-558. doi:10.1200/JCO.2014.57.9151PALBI-An Objective Score Based on Platelets, Albumin & Bilirubin Stratifies HCC Patients Undergoing Resection & Ablation Better than Child's Classification (Conference Paper)
Roayaie, S., Jibara, G., Berhane, S., Tabrizian, P., Park, J. -W., Yang, J., . . . Johnson, P. (2015). PALBI-An Objective Score Based on Platelets, Albumin & Bilirubin Stratifies HCC Patients Undergoing Resection & Ablation Better than Child's Classification. In HEPATOLOGY Vol. 62 (pp. 631A-632A). Retrieved from https://www.webofscience.com/Survival After Intra-Arterial Treatment for Hepatocellular Carcinoma: Impact of Liver Dysfunction and Development of a Predictive Statistical Model: an International Collaborative Project (Conference Paper)
Waked, I., Berhane, S., Chan, S. L., Gomaa, A., Inarrairaegui, M., Alkhatib, Z., . . . Johnson, P. (2015). Survival After Intra-Arterial Treatment for Hepatocellular Carcinoma: Impact of Liver Dysfunction and Development of a Predictive Statistical Model: an International Collaborative Project. In HEPATOLOGY Vol. 62 (pp. 384A-385A). Retrieved from https://www.webofscience.com/2014
Hepatocellular carcinoma (Chapter)
Palmer, D. H., & Johnson, P. J. (2014). Hepatocellular carcinoma. In Treatment of Cancer (pp. 201-212). CRC Press. doi:10.1201/b17751-9Assessment of liver dysfunction in hepatocellular carcinoma (HCC): An international collaborative study. (Conference Paper)
Johnson, P. J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M. J., Skowronska, A., . . . Kumada, T. (2014). Assessment of liver dysfunction in hepatocellular carcinoma (HCC): An international collaborative study.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 32. doi:10.1200/jco.2014.32.15_suppl.4094Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry (Journal article)
Desai, R., Collett, D., Watson, C. J. E., Johnson, P., Evans, T., & Neuberger, J. (2014). Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry. British Journal of Surgery, 101(7), 768-774. doi:10.1002/bjs.9460Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma (Journal article)
Teng, M., Pirrie, S., Ward, D. G., Assi, L. K., Hughes, R. G., Stocken, D., & Johnson, P. J. (2014). Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma. BRITISH JOURNAL OF CANCER, 110(9), 2277-2282. doi:10.1038/bjc.2014.121Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model (Journal article)
Fox, R., Berhane, S., Teng, M., Cox, T., Tada, T., Toyoda, H., . . . Johnson, P. J. (2014). Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model. British Journal of Cancer, 110(8), 2090-2098. doi:10.1038/bjc.2014.130AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC - IMPLICATIONS FOR SCREENING (Conference Paper)
Johnson, P., Berhane, S., Satomura, S., Tada, T., Kumada, T., Teng, M., . . . Toyoda, H. (2014). AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC - IMPLICATIONS FOR SCREENING. In JOURNAL OF HEPATOLOGY Vol. 60 (pp. S45-S46). doi:10.1016/S0168-8278(14)60112-4ASSESSMENT OF PROGNOSIS IN HEPATOCELLULAR CARCINOMA USING A BIOMARKER BASED APPROACH: VALIDATION AND EXTENSION OF THE BALAD MODEL (Conference Paper)
Fox, R., Berhane, S., Teng, M., Cox, T., Tada, T., Toyoda, H., . . . Johnson, P. (2014). ASSESSMENT OF PROGNOSIS IN HEPATOCELLULAR CARCINOMA USING A BIOMARKER BASED APPROACH: VALIDATION AND EXTENSION OF THE BALAD MODEL. In JOURNAL OF HEPATOLOGY Vol. 60 (pp. S254). doi:10.1016/S0168-8278(14)60716-9Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage? (Journal article)
Llovet, J. M., & Johnson, P. J. (2014). Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?. JOURNAL OF CLINICAL ONCOLOGY, 32(9), 968-969. doi:10.1200/JCO.2013.53.8199Reply to X. Qi et al. (Journal article)
Llovet, J. M., & Johnson, P. J. (2014). Reply to X. Qi et al.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(9), 968-969. doi:10.1200/jco.2013.54.3033Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma. (Journal article)
Qi, Y. -J., Ward, D. G., Pang, C., Wang, Q. -M., Wei, W., Ma, J., . . . Johnson, P. J. (2014). Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.. Proteomics, 14(2-3), 186-195. doi:10.1002/pmic.201300226Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers (Journal article)
Malottki, K., Biswas, M., Deeks, J. J., Riley, R. D., Craddock, C., Johnson, P., & Billingham, L. (2014). Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers. BMJ OPEN, 4(1). doi:10.1136/bmjopen-2013-004188A joint United Kingdom (UK) and Hong Kong (HK) study to determine prognostic factors for hepatocellular carcinoma (HCC) undergoing curative and palliative treatment (Conference Paper)
Chan, S. L., Johnson, P. J., Mo, F., Berhane, S., Ma, B., Teng, M., . . . Yeo, W. (2014). A joint United Kingdom (UK) and Hong Kong (HK) study to determine prognostic factors for hepatocellular carcinoma (HCC) undergoing curative and palliative treatment. In JOURNAL OF CLINICAL ONCOLOGY Vol. 32. doi:10.1200/jco.2014.32.3_suppl.181International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study. (Journal article)
Chan, S. L., Johnson, P. J., Mo, F., Berhane, S., Teng, M., Chan, A. W. H., . . . Yeo, W. (2014). International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study.. Chinese journal of cancer, 33(10), 481-491. doi:10.5732/cjc.014.10133Performance of serum a-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass (Journal article)
Chan, S. L., Mo, F., Johnson, P. J., Siu, D. Y. W., Chan, M. H. M., Lau, W. Y., . . . Yu, S. C. H. (2014). Performance of serum a-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass. HPB, 16(4), 366-372. doi:10.1111/hpb.12146The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers (Journal article)
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M. J., Palmer, D. H., . . . Satomura, S. (2014). The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers. Cancer Epidemiology, Biomarkers and Prevention, 23(1), 144-153. doi:10.1158/1055-9965.EPI-13-0870The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers. (Journal article)
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M., Palmer, D., . . . Satomura, S. (2014). The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers.. Cancer Epidemiology Biomarkers Preview.2013
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study. (Journal article)
Johnson, P. J., Qin, S., Park, J. -W., Poon, R. T. P., Raoul, J. -L., Philip, P. A., . . . Cheng, A. -L. (2013). Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(28), 3517-3524. doi:10.1200/jco.2012.48.4410Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom (Journal article)
Palmer, D. H., Hussain, S. A., Smith, A. J., Hargreaves, S., Ma, Y. T., Hull, D., . . . Ross, P. J. (2013). Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom. BRITISH JOURNAL OF CANCER, 109(4), 888-890. doi:10.1038/bjc.2013.410Sorafenib for Advanced Hepatocellular Carcinoma (HCC): Impact of rationing in the United Kingdom (Journal article)
Palmer, D. H., Hussain, S. A., Smith, A. J., Hull, D., Johnson, P. J., & Ross, P. (2013). Sorafenib for Advanced Hepatocellular Carcinoma (HCC): Impact of rationing in the United Kingdom. British Journal of cancer, 109(4), 888-890. doi:10.1038/bjc.2013.410Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective. (Journal article)
Colombo, M., Raoul, J. -L., Lencioni, R., Galle, P. R., Zucman-Rossi, J., Bañares, R., . . . Johnson, P. (2013). Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.. European journal of gastroenterology & hepatology, 25(6), 639-651. doi:10.1097/meg.0b013e32835e33bbCombined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma. (Journal article)
Shimwell, N. J., Bryan, R. T., Wei, W., James, N. D., Cheng, K. K., Zeegers, M. P., . . . Ward, D. G. (2013). Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma.. British journal of cancer, 108(9), 1854-1861. doi:10.1038/bjc.2013.157MALDI profiles of proteins and lipids for the rapid characterisation of upper GI-tract cancers. (Journal article)
Singhal, R., Carrigan, J. B., Wei, W., Taniere, P., Hejmadi, R. K., Forde, C., . . . Ward, D. G. (2013). MALDI profiles of proteins and lipids for the rapid characterisation of upper GI-tract cancers.. Journal of proteomics, 80, 207-215. doi:10.1016/j.jprot.2013.01.016Production of nanoparticles-in-microparticles by a double emulsion method: a comprehensive study. (Journal article)
Lee, Y. -S., Johnson, P. J., Robbins, P. T., & Bridson, R. H. (2013). Production of nanoparticles-in-microparticles by a double emulsion method: a comprehensive study.. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 83(2), 168-173. doi:10.1016/j.ejpb.2012.10.016A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer. (Journal article)
Kadalayil, L., Benini, R., Pallan, L., O'Beirne, J., Marelli, L., Yu, D., . . . Meyer, T. (2013). A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.. Annals of oncology : official journal of the European Society for Medical Oncology, 24(10), 2565-2570. doi:10.1093/annonc/mdt247How do mechanisms of hepatocarcinogenesis (HBV, HCV, and NASH) affect our understanding and approach to HCC? (Journal article)
Johnson, P. J. (2013). How do mechanisms of hepatocarcinogenesis (HBV, HCV, and NASH) affect our understanding and approach to HCC?. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. doi:10.14694/edbook_am.2013.33.e1322012
Cancer transmission from organ donors-unavoidable but low risk. (Journal article)
Desai, R., Collett, D., Watson, C. J., Johnson, P., Evans, T., & Neuberger, J. (2012). Cancer transmission from organ donors-unavoidable but low risk.. Transplantation, 94(12), 1200-1207. doi:10.1097/tp.0b013e318272df41Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas. (Journal article)
Shimwell, N. J., Ward, D. G., Mohri, Y., Mohri, T., Pallan, L., Teng, M., . . . Johnson, P. J. (2012). Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas.. British journal of cancer, 107(9), 1595-1601. doi:10.1038/bjc.2012.405Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery. (Journal article)
Barea, M. J., Jenkins, M. J., Lee, Y. S., Johnson, P., & Bridson, R. H. (2012). Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery.. International journal of biomaterials, 2012, 458712. doi:10.1155/2012/458712Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspective. (Journal article)
Chan, S. L., & Johnson, P. (2012). Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspective.. Asia-Pacific journal of clinical oncology, 8(2), 111-114. doi:10.1111/j.1743-7563.2012.01551.xSample size calculations for designing clinical proteomic profiling studies using mass spectrometry. (Journal article)
Nyangoma, S. O., Collins, S. I., Altman, D. G., Johnson, P., & Billingham, L. J. (2012). Sample size calculations for designing clinical proteomic profiling studies using mass spectrometry.. Statistical applications in genetics and molecular biology, 11(3), Article-2. doi:10.1515/1544-6115.16862011
Decrease of serum protein concentration difference by solid-phase ligand libraries (Journal article)
Qi, Y. J., Niu, R. H., Wang, P., Hou, Y. F., Chao, W. X., Ma, Y. F., . . . Johnson, P. J. (2011). Decrease of serum protein concentration difference by solid-phase ligand libraries. Acta Anatomica Sinica, 42(6), 770-774. doi:10.3969/j.issn.0529-1356.2011.06.011Justification for Sorafenib and Chemotherapy (Chapter)
Johnson, P. J. (2011). Justification for Sorafenib and Chemotherapy. In Unknown Book (pp. 154-159). Wiley. doi:10.1002/9781119962205.ch22Cytotoxic Chemotherapy and Endocrine Therapy for Hepatocellular Carcinoma (Chapter)
Palmer, D., & Johnson, P. J. (2011). Cytotoxic Chemotherapy and Endocrine Therapy for Hepatocellular Carcinoma. In Hepatocellular Carcinoma: (pp. 337-353). Springer New York. doi:10.1007/978-1-60327-522-4_21Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer (Journal article)
Bryan, R. T., Wei, W., Shimwell, N. J., Collins, S. I., Hussain, S. A., Billingham, L. J., . . . Ward, D. G. (2011). Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer. PROTEOMICS CLINICAL APPLICATIONS, 5(9-10), 493-503. doi:10.1002/prca.201100011EFFECTIVENESS OF TRANS-ARTERIAL EMBOLISATION OF LIVER NEUROENDOCRINE TUMOUR METASTASES (Conference Paper)
Mandair, D. S., Bridgestock, H., Shah, T., Mangat, K., Olliff, S., Mahon, B., . . . Palmer, D. (2011). EFFECTIVENESS OF TRANS-ARTERIAL EMBOLISATION OF LIVER NEUROENDOCRINE TUMOUR METASTASES. In GUT Vol. 60. doi:10.1136/gut.2011.239301.243Assessment of novel combinations of biomarkers for the detection of colorectal cancer. (Journal article)
Shimwell, N. J., Wei, W., Wilson, S., Wakelam, M. J. O., Ismail, T., Iqbal, T., . . . Ward, D. G. (2010). Assessment of novel combinations of biomarkers for the detection of colorectal cancer.. Cancer biomarkers : section A of Disease markers, 7(3), 123-132. doi:10.3233/cbm-2010-0155Hepatobiliary tumours (Journal article)
Johnson, P. J. (2011). Hepatobiliary tumours. Medicine, 39(10), 630-633. doi:10.1016/j.mpmed.2011.07.009Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population. (Journal article)
Chan, S. L., Mo, F. K. F., Johnson, P. J., Liem, G. S., Chan, T. C., Poon, M. C., . . . Yeo, W. (2011). Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.. Journal of gastroenterology and hepatology, 26(2), 340-347. doi:10.1111/j.1440-1746.2010.06329.x2010
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. (Journal article)
Abou-Alfa, G. K., Johnson, P., Knox, J. J., Capanu, M., Davidenko, I., Lacava, J., . . . Saltz, L. B. (2010). Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.. JAMA, 304(19), 2154-2160. doi:10.1001/jama.2010.1672Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogen. (Journal article)
Ward, D. G., Wei, W., Buckels, J., Taha, A. M. I., Hegab, B., Tariciotti, L., . . . Johnson, P. J. (2010). Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogen.. European journal of gastroenterology & hepatology, 22(11), 1358-1363. doi:10.1097/meg.0b013e32833b6d4110 Years of SELDI: What Have we Learnt? (Journal article)
Wei, W., Martin, A., Johnson, P., & Ward, D. (2010). 10 Years of SELDI: What Have we Learnt?. Current Proteomics, 7(1), 15-25. doi:10.2174/157016410790979617Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference. (Conference Paper)
Dufour, J. -F., & Johnson, P. (2010). Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference.. In Journal of hepatology Vol. 52 (pp. 296-304). doi:10.1016/j.jhep.2009.11.0102009
Confounding Effects of Benign Lung Diseases on Non-Small Cell Lung Cancer Serum Biomarker Discovery (Journal article)
Rathinam, S., Alzetani, A., Starczynski, J., Rajesh, P. B., Nyangoma, S., Wakelam, M. J. O., . . . Ward, D. G. (2009). Confounding Effects of Benign Lung Diseases on Non-Small Cell Lung Cancer Serum Biomarker Discovery. Clinical Proteomics, 5(3-4), 148-155. doi:10.1007/s12014-009-9033-4Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer. (Journal article)
Mohri, Y., Mohri, T., Wei, W., Qi, Y. -J., Martin, A., Miki, C., . . . Johnson, P. J. (2009). Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.. British journal of cancer, 101(2), 295-302. doi:10.1038/sj.bjc.6605138TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance. (Journal article)
Wong, N., Yeo, W., Wong, W. -L., Wong, N. L. -Y., Chan, K. Y. -Y., Mo, F. K. -F., . . . To, K. -F. (2009). TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.. International journal of cancer, 124(3), 644-652. doi:10.1002/ijc.23968New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. (Journal article)
Chan, S. L., Mo, F. K. F., Johnson, P. J., Hui, E. P., Ma, B. B. Y., Ho, W. M., . . . Yeo, W. (2009). New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27(3), 446-452. doi:10.1200/jco.2008.18.8151Fast targeted multidimensional NMR metabolomics of colorectal cancer. (Journal article)
Ludwig, C., Ward, D. G., Martin, A., Viant, M. R., Ismail, T., Johnson, P. J., . . . Günther, U. L. (2009). Fast targeted multidimensional NMR metabolomics of colorectal cancer.. Magnetic resonance in chemistry : MRC, 47 Suppl 1, S68-S73. doi:10.1002/mrc.2519Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison (Journal article)
Cairns, D. A., Barrett, J. H., Billingham, L. J., Stanley, A. J., Xinarianos, G., Field, J. K., . . . Banks, R. E. (2009). Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison. PROTEOMICS, 9(1), 74-86. doi:10.1002/pmic.200800417Sorafenib for liver cancer: the horizon broadens. (Journal article)
Johnson, P., & Billingham, L. (2009). Sorafenib for liver cancer: the horizon broadens.. The Lancet. Oncology, 10(1), 4-5. doi:10.1016/s1470-2045(08)70317-62008
The clinical management of hepatic neoplasms (Chapter)
Palmer, D., & Johnson, P. (2008). The clinical management of hepatic neoplasms. In Interventional Radiological Treatment of Liver Tumors (pp. 1-24). Cambridge University Press. doi:10.1017/cbo9780511575433.003SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard. (Journal article)
Ward, D. G., Roberts, K., Stonelake, P., Goon, P., Zampronio, C. G., Martin, A., . . . Tselepis, C. (2008). SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard.. Proteome science, 6, 28. doi:10.1186/1477-5956-6-28Modelling prognostic factors in advanced pancreatic cancer. (Journal article)
Stocken, D. D., Hassan, A. B., Altman, D. G., Billingham, L. J., Bramhall, S. R., Johnson, P. J., & Freemantle, N. (2008). Modelling prognostic factors in advanced pancreatic cancer.. British journal of cancer, 99(6), 883-893. doi:10.1038/sj.bjc.6604568Hepatocellular Carcinoma: Epidemiology, Pathology, Diagnosis and Screening (Chapter)
Johnson, P. (2008). Hepatocellular Carcinoma: Epidemiology, Pathology, Diagnosis and Screening. In Interventional Oncology (pp. 101-106). Cambridge University Press. doi:10.1017/cbo9780511722226.010Hepatocellular Carcinoma: Medical Management (Chapter)
Johnson, P., & Palmer, D. (2008). Hepatocellular Carcinoma: Medical Management. In Interventional Oncology (pp. 115-120). Cambridge University Press. doi:10.1017/cbo9780511722226.012Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer (Journal article)
Palmer, D. H., Stocken, D. D., Hewitt, H., Markham, C. E., Hassan, A. B., Johnson, P. J., . . . Bramhall, S. R. (2008). Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer. Annals of Surgical Oncology, 15(7), 2061. doi:10.1245/s10434-008-9921-2Proteomic profiling of urine for the detection of colon cancer. (Journal article)
Ward, D. G., Nyangoma, S., Joy, H., Hamilton, E., Wei, W., Tselepis, C., . . . Martin, A. (2008). Proteomic profiling of urine for the detection of colon cancer.. Proteome science, 6, 19. doi:10.1186/1477-5956-6-19Liver (Chapter)
Liver (2008). In Treatment of Cancer (pp. 583-596). CRC Press. doi:10.1201/b13550-29Biology of hepatocellular carcinoma. (Conference Paper)
Pang, R. W. C., Joh, J. W., Johnson, P. J., Monden, M., Pawlik, T. M., & Poon, R. T. P. (2008). Biology of hepatocellular carcinoma.. In Annals of surgical oncology Vol. 15 (pp. 962-971). doi:10.1245/s10434-007-9730-zSystemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. (Conference Paper)
Thomas, M. B., O'Beirne, J. P., Furuse, J., Chan, A. T. C., Abou-Alfa, G., & Johnson, P. (2008). Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy.. In Annals of surgical oncology Vol. 15 (pp. 1008-1014). doi:10.1245/s10434-007-9705-02007
A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin. (Journal article)
Palmer, D. H., Stocken, D. D., Hewitt, H., Markham, C. E., Hassan, A. B., Johnson, P. J., . . . Bramhall, S. R. (2007). A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.. Annals of surgical oncology, 14(7), 2088-2096. doi:10.1245/s10434-007-9384-xA double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity. (Journal article)
Mok, T. S. K., Yeo, W., Johnson, P. J., Hui, P., Ho, W. M., Lam, K. C., . . . Zee, B. (2007). A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity.. Annals of oncology : official journal of the European Society for Medical Oncology, 18(4), 768-774. doi:10.1093/annonc/mdl465New medical options for liver tumours. (Journal article)
Williams, S., Palmer, D., & Johnson, P. (2007). New medical options for liver tumours.. Clinical medicine (London, England), 7(4), 351-356. doi:10.7861/clinmedicine.7-4-3512006
Malignant Tumors of the Liver (Chapter)
JOHNSON, P. (2006). Malignant Tumors of the Liver. In Comprehensive Clinical Hepatology (pp. 453-472). Elsevier. doi:10.1016/b978-0-323-03675-7.50033-0Preclinical and post-treatment changes in the HCC-associated serum proteome. (Journal article)
Ward, D. G., Cheng, Y., N'Kontchou, G., Thar, T. T., Barget, N., Wei, W., . . . Johnson, P. J. (2006). Preclinical and post-treatment changes in the HCC-associated serum proteome.. British journal of cancer, 95(10), 1379-1383. doi:10.1038/sj.bjc.6603429A comparison of wound treatments in nasopharyngeal cancer patients receiving radiation therapy. (Journal article)
Mak, S. S., Zee, C. Y., Molassiotis, A., Chan, S. J., Leung, S. F., Mo, K. F., & Johnson, P. J. (2005). A comparison of wound treatments in nasopharyngeal cancer patients receiving radiation therapy.. Cancer nursing, 28(6), 436-445. doi:10.1097/00002820-200511000-00005Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. (Journal article)
Ang, I. L., Poon, T. C. W., Lai, P. B. S., Chan, A. T. C., Ngai, S. -M., Hui, A. Y., . . . Sung, J. J. Y. (2006). Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.. Journal of proteome research, 5(10), 2691-2700. doi:10.1021/pr060109rPrinciples of cancer treatment (Conference Paper)
Johnson, P. J. (2006). Principles of cancer treatment. In CardioVascular and Interventional Radiology Vol. 29 (pp. 158).Novel identification of zyxin upregulations in the motile phenotype of hepatocellular carcinoma. (Journal article)
Sy, S. M. -H., Lai, P. B. -S., Pang, E., Wong, N. L. -Y., To, K. -F., Johnson, P. J., & Wong, N. (2006). Novel identification of zyxin upregulations in the motile phenotype of hepatocellular carcinoma.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 19(8), 1108-1116. doi:10.1038/modpathol.3800626Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. (Journal article)
Yeo, W., Mo, F. K. F., Koh, J., Chan, A. T. C., Leung, T., Hui, P., . . . Zee, B. (2006). Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.. Annals of oncology : official journal of the European Society for Medical Oncology, 17(7), 1083-1089. doi:10.1093/annonc/mdl065Identification of serum biomarkers for colon cancer by proteomic analysis. (Journal article)
Ward, D. G., Suggett, N., Cheng, Y., Wei, W., Johnson, H., Billingham, L. J., . . . Martin, A. (2006). Identification of serum biomarkers for colon cancer by proteomic analysis.. British journal of cancer, 94(12), 1898-1905. doi:10.1038/sj.bjc.6603188Plasma proteome analysis reveals the geographical origin and liver tumor status of Dab (Limanda limanda) from UK marine waters. (Journal article)
Ward, D. G., Wei, W., Cheng, Y., Billingham, L. J., Martin, A., Johnson, P. I., . . . Stentiford, G. D. (2006). Plasma proteome analysis reveals the geographical origin and liver tumor status of Dab (Limanda limanda) from UK marine waters.. Environmental science & technology, 40(12), 4031-4036. doi:10.1021/es052436qDiagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. (Journal article)
Yeo, W., & Johnson, P. J. (2006). Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.. Hepatology (Baltimore, Md.), 43(2), 209-220. doi:10.1002/hep.21051Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. (Journal article)
Ward, D. G., Cheng, Y., N'Kontchou, G., Thar, T. T., Barget, N., Wei, W., . . . Johnson, P. J. (2006). Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis.. British journal of cancer, 94(2), 287-292. doi:10.1038/sj.bjc.6602923A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data. (Journal article)
Poon, T. C. W., Wong, N., Lai, P. B. S., Rattray, M., Johnson, P. J., & Sung, J. J. Y. (2006). A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.. Gastroenterology, 131(4), 1262-1270. doi:10.1053/j.gastro.2006.08.0142005
Control of malignant ascites with spironolactone. (Journal article)
Greenway, B., Johnson, P. J., & Williams, R. (1982). Control of malignant ascites with spironolactone.. The British journal of surgery, 69(8), 441-442. doi:10.1002/bjs.1800690802Malignant Tumors of the Liver (Chapter)
Johnson, P. J. (2005). Malignant Tumors of the Liver. In Comprehensive Clinical Hepatology: Text with CD-ROM (pp. 453-472). doi:10.1016/B978-0-323-03675-7.50033-0The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy. (Journal article)
Greenway, B., Duke, D., Pym, B., Iqbal, M. J., Johnson, P. J., & Williams, R. (1982). The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy.. The British journal of surgery, 69(10), 595-597. doi:10.1002/bjs.1800691013Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma. (Journal article)
Poon, T. C. W., Chiu, C. H. S., Lai, P. B. S., Mok, T. S. K., Zee, B., Chan, A. T. C., . . . Johnson, P. J. (2005). Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.. World journal of gastroenterology, 11(42), 6701-6706. doi:10.3748/wjg.v11.i42.6701An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results. (Journal article)
Mok, T. S. K., Yeo, W., Yu, S., Lai, P., Chan, H. L. Y., Chan, A. T. C., . . . Johnson, P. J. (2005). An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23(31), 8041-8047. doi:10.1200/jco.2005.01.9927Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic study. (Journal article)
Stentiford, G. D., Viant, M. R., Ward, D. G., Johnson, P. J., Martin, A., Wenbin, W., . . . Feist, S. W. (2005). Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic study.. Omics : a journal of integrative biology, 9(3), 281-299. doi:10.1089/omi.2005.9.281A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. (Journal article)
Yeo, W., Mok, T. S., Zee, B., Leung, T. W. T., Lai, P. B. S., Lau, W. Y., . . . Johnson, P. J. (2005). A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.. Journal of the National Cancer Institute, 97(20), 1532-1538. doi:10.1093/jnci/dji315Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine. (Journal article)
Yeo, W., Hui, E. P., Chan, A. T. C., Ho, W. M., Lam, K. C., Chan, P. K. S., . . . Johnson, P. J. (2005). Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.. American journal of clinical oncology, 28(4), 379-384. doi:10.1097/01.coc.0000159554.97885.88Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma. (Journal article)
Chan, K. Y. -Y., Wong, N., Lai, P. B. -S., Squire, J. A., Macgregor, P. F., Beheshti, B., . . . Johnson, P. J. (2005). Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma.. International journal of cancer, 114(6), 902-908. doi:10.1002/ijc.20684Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma. (Journal article)
Sy, S. M. -H., Wong, N., Lai, P. B. -S., To, K. -F., & Johnson, P. J. (2005). Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 18(5), 686-692. doi:10.1038/modpathol.3800345Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. (Journal article)
Chan, A. T. C., Leung, S. F., Ngan, R. K. C., Teo, P. M. L., Lau, W. H., Kwan, W. H., . . . Zee, B. C. Y. (2005). Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.. Journal of the National Cancer Institute, 97(7), 536-539. doi:10.1093/jnci/dji084Gene- and immunotherapy for hepatocellular carcinoma (Journal article)
Palmer, D. H., Hussain, S. A., & Johnson, P. J. (2005). Gene- and immunotherapy for hepatocellular carcinoma. EXPERT OPINION ON BIOLOGICAL THERAPY, 5(4), 507-523. doi:10.1517/14712598.5.4.507High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma. (Journal article)
Yeo, W., Wong, N., Wong, W. -L., Lai, P. B. S., Zhong, S., & Johnson, P. J. (2005). High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.. Liver international : official journal of the International Association for the Study of the Liver, 25(2), 266-272. doi:10.1111/j.1478-3231.2005.01084.xPre-operative locoregional therapy and liver transplantation for hepatocellular carcinoma: time for a randomized controlled trial. (Journal article)
Palmer, D. H., & Johnson, P. J. (2005). Pre-operative locoregional therapy and liver transplantation for hepatocellular carcinoma: time for a randomized controlled trial.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 5(4 Pt 1), 641-642. doi:10.1111/j.1600-6143.2005.00856.xClinical trial design in hepatocellular carcinoma. (Journal article)
Johnson, P. J., & Billingham, L. J. (2005). Clinical trial design in hepatocellular carcinoma.. Best practice & research. Clinical gastroenterology, 19(1), 119-127. doi:10.1016/j.bpg.2004.11.004Non-surgical treatment of hepatocellular carcinoma. (Journal article)
Johnson, P. J. (2005). Non-surgical treatment of hepatocellular carcinoma.. HPB : the official journal of the International Hepato Pancreato Biliary Association, 7(1), 50-55. doi:10.1080/136518204100240762004
Systemic therapies for hepatocellular carcinoma (Journal article)
Palmer, D. H., Hussain, S. A., & Johnson, P. J. (2004). Systemic therapies for hepatocellular carcinoma. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 13(12), 1555-1568. doi:10.1517/13543784.13.12.1555Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients. (Journal article)
Yeo, W., Ho, W. M., Hui, P., Chan, P. K. S., Lam, K. C., Lee, J. J., & Johnson, P. J. (2004). Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.. Breast cancer research and treatment, 88(3), 209-215. doi:10.1007/s10549-004-0725-1Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy. (Journal article)
Yeo, W., Lam, K. C., Zee, B., Chan, P. S. K., Mo, F. K. F., Ho, W. M., . . . Johnson, P. J. (2004). Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.. Annals of oncology : official journal of the European Society for Medical Oncology, 15(11), 1661-1666. doi:10.1093/annonc/mdh430Technical evaluation of MALDI-TOF mass spectrometry for quantitative proteomic profiling matrix formulation and application (Journal article)
Pang, R. T. K., Johnson, P. J., Chan, C. M. L., Kong, E. K. C., Chan, A. T. C., Sung, J. J. Y., & Poon, T. C. W. (2004). Technical evaluation of MALDI-TOF mass spectrometry for quantitative proteomic profiling matrix formulation and application. Clinical Proteomics, 1(3-4), 259-270. doi:10.1385/cp:1:3-4:259Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. (Journal article)
Chan, A. T. C., Ma, B. B. Y., Lo, Y. M. D., Leung, S. F., Kwan, W. H., Hui, E. P., . . . Zee, B. (2004). Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22(15), 3053-3060. doi:10.1200/jco.2004.05.178A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer. (Journal article)
Mok, T. S. K., Leung, T. W. T., Brown, G., Moyses, C., Chan, A. T. C., Yeo, W., . . . Johnson, P. (2004). A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer.. Acta oncologica (Stockholm, Sweden), 43(3), 245-251. doi:10.1080/02841860310023525Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. (Journal article)
Sy, S. M. -H., Wong, N., Lee, T. -W., Tse, G., Mok, T. S. -K., Fan, B., . . . Yim, A. (2004). Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung.. European journal of cancer (Oxford, England : 1990), 40(7), 1082-1094. doi:10.1016/j.ejca.2004.01.012Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors. (Journal article)
Chan, A. T. C., Tao, Q., Robertson, K. D., Flinn, I. W., Mann, R. B., Klencke, B., . . . Ambinder, R. F. (2004). Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22(8), 1373-1381. doi:10.1200/jco.2004.04.185Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. (Journal article)
Yeo, W., Zee, B., Zhong, S., Chan, P. K. S., Wong, W. -L., Ho, W. M., . . . Johnson, P. J. (2004). Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.. British journal of cancer, 90(7), 1306-1311. doi:10.1038/sj.bjc.6601699Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. (Journal article)
Yeo, W., Chan, P. K. S., Ho, W. M., Zee, B., Lam, K. C., Lei, K. I. K., . . . Johnson, P. J. (2004). Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22(5), 927-934. doi:10.1200/jco.2004.05.161Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nonnasopharyngeal head and neck carcinomas. (Journal article)
Yu, K. H., Lo, Y. M. D., Tse, G. M., Chan, K. C. A., Chan, A. B. W., Chow, K. C. K., . . . Chan, A. T. C. (2004). Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nonnasopharyngeal head and neck carcinomas.. Clinical cancer research : an official journal of the American Association for Cancer Research, 10(5), 1726-1732. doi:10.1158/1078-0432.ccr-0991-3Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody. (Journal article)
Leung, S. -F., Tam, J. S., Chan, A. T. C., Zee, B., Chan, L. Y. S., Huang, D. P., . . . Lo, Y. M. D. (2004). Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.. Clinical chemistry, 50(2), 339-345. doi:10.1373/clinchem.2003.022426Psychosocial impact of breast cancer surgeries in Chinese patients and their spouses. (Journal article)
Yeo, W., Kwan, W. H., Teo, P. M. L., Nip, S., Wong, E., Hin, L. Y., & Johnson, P. J. (2004). Psychosocial impact of breast cancer surgeries in Chinese patients and their spouses.. Psycho-oncology, 13(2), 132-139. doi:10.1002/pon.777False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels. (Journal article)
Mok, T. S. K., Yu, S. C. H., Lee, C., Sung, J., Leung, N., Lai, P., . . . Johnson, P. (2004). False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.. AJR. American journal of roentgenology, 183(2), 453-458. doi:10.2214/ajr.183.2.1830453High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy. (Journal article)
Zhong, S., Yeo, W., Schroder, C., Chan, P. K. S., Wong, W. -L., Ho, W. M., . . . Johnson, P. J. (2004). High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy.. Journal of viral hepatitis, 11(1), 55-59. doi:10.1046/j.1352-0504.2003.00467.xNutritional consequences of radiotherapy in nasopharynx cancer patients. (Journal article)
Ng, K., Leung, S. F., Johnson, P. J., & Woo, J. (2004). Nutritional consequences of radiotherapy in nasopharynx cancer patients.. Nutrition and cancer, 49(2), 156-161. doi:10.1207/s15327914nc4902_62003
Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese. (Journal article)
Heneghan, M. A., Johnson, P. J., Clare, M., Ho, S., Harrison, P. M., & Donaldson, P. T. (2003). Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese.. International journal of gastrointestinal cancer, 34(1), 19-26. doi:10.1385/ijgc:34:1:19HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. (Journal article)
Midgley, R. S., Bell, A. I., Yao, Q. Y., Croom-Carter, D., Hislop, A. D., Whitney, B. M., . . . Rickinson, A. B. (2003). HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.. Journal of virology, 77(21), 11507-11516. doi:10.1128/jvi.77.21.11507-11516.2003Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study. (Journal article)
Ma, B. B. Y., Poon, T. C. W., To, K. F., Zee, B., Mo, F. K. F., Chan, C. M. L., . . . Chan, A. T. C. (2003). Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.. Head & neck, 25(10), 864-872. doi:10.1002/hed.10307Quality of life of palliative care patients in the last two weeks of life. (Journal article)
Lo, R. S. K., Woo, J., Zhoc, K. C. H., Li, C. Y. P., Yeo, W., Johnson, P., . . . Lee, J. (2002). Quality of life of palliative care patients in the last two weeks of life.. Journal of pain and symptom management, 24(4), 388-397. doi:10.1016/s0885-3924(02)00504-3Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2. (Journal article)
Leung, S. -F., Lo, Y. M. D., Chan, A. T. C., To, K. -F., To, E., Chan, L. Y. S., . . . Johnson, P. J. (2003). Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2.. Clinical cancer research : an official journal of the American Association for Cancer Research, 9(9), 3431-3434.Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. (Journal article)
Zhong, S., Yeo, W., Tang, M. W., Wong, N., Lai, P. B. S., & Johnson, P. J. (2003). Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.. Clinical cancer research : an official journal of the American Association for Cancer Research, 9(9), 3376-3382.Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. (Journal article)
To, E. W. H., Chan, K. C. A., Leung, S. -F., Chan, L. Y. S., To, K. -F., Chan, A. T. C., . . . Lo, Y. M. D. (2003). Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 9(9), 3254-3259.Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study. (Journal article)
Yeo, W., Chan, P. K. S., Hui, P., Ho, W. M., Lam, K. C., Kwan, W. H., . . . Johnson, P. J. (2003). Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.. Journal of medical virology, 70(4), 553-561. doi:10.1002/jmv.10430Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. (Journal article)
Leung, S. -F., Chan, A. T. C., Zee, B., Ma, B., Chan, L. Y. S., Johnson, P. J., & Lo, Y. M. D. (2003). Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.. Cancer, 98(2), 288-291. doi:10.1002/cncr.11496Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity. (Journal article)
Sy, S. M. H., Wong, N., Mok, T. S. K., Tsao, M. -S., Lee, T. -W., Tse, G., . . . Yim, A. P. (2003). Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity.. Lung cancer (Amsterdam, Netherlands), 41(1), 91-99. doi:10.1016/s0169-5002(03)00138-7Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. (Journal article)
Poon, T. C. W., Yip, T. -T., Chan, A. T. C., Yip, C., Yip, V., Mok, T. S. K., . . . Johnson, P. J. (2003). Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes.. Clinical chemistry, 49(5), 752-760. doi:10.1373/49.5.752Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression. (Journal article)
Wong, N., Chan, A., Lee, S. -W., Lam, E., To, K. -F., Lai, P. B. -S., . . . Johnson, P. J. (2003). Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.. Journal of hepatology, 38(3), 298-306. doi:10.1016/s0168-8278(02)00412-9Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma. (Journal article)
Leung, T. W. T., Yu, S., Johnson, P. J., Geschwind, J., Vogl, T. J., Engelmann, K., . . . Thuluvath, P. J. (2003). Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21(4), 652-658. doi:10.1200/jco.2003.04.152Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping. (Journal article)
Wong, N., Hui, A. B. Y., Fan, B., Lo, K. W., Pang, E., Leung, S. -F., . . . Johnson, P. J. (2003). Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping.. Cancer genetics and cytogenetics, 140(2), 124-132. doi:10.1016/s0165-4608(02)00657-xA prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma. (Journal article)
Hui, E. P., Poon, T. C. W., Teo, P. M. L., Mo, F., Zee, B., Leung, S. F., . . . Chan, A. T. C. (2003). A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 69(1), 53-62. doi:10.1016/s0167-8140(03)00248-2Are there indications for chemotherapy in hepatocellular carcinoma? (Journal article)
Johnson, P. J. (2003). Are there indications for chemotherapy in hepatocellular carcinoma?. Surgical oncology clinics of North America, 12(1), 127-134. doi:10.1016/s1055-3207(02)00075-3Critical issues in the design and implementation of clinical trials in hepatocellular carcinoma. (Journal article)
Johnson, P. J. (2003). Critical issues in the design and implementation of clinical trials in hepatocellular carcinoma.. Expert review of anticancer therapy, 3(4), 421-423. doi:10.1586/14737140.3.4.421Nasopharyngeal cancer. (Journal article)
Chan, A. T. C., Teo, P. M. L., & Johnson, P. J. (2003). Nasopharyngeal cancer.. Cancer treatment and research, 114, 275-293. doi:10.1007/0-306-48060-3_11Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. (Journal article)
Cheng, A. S. L., Chan, H. L. Y., Leung, W. K., Wong, N., Johnson, P. J., & Sung, J. J. Y. (2003). Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.. International journal of oncology, 23(1), 113-119.2002
Phase II study of combination cisplatin and adriamycin in recurrent carcinoma of the nasopharynx (Journal article)
Yeo, W., Leung, T. W. T., Chan, A. T. C., Chiu, K. W., Yu, P., Mok, T., & Johnson, P. J. (2002). Phase II study of combination cisplatin and adriamycin in recurrent carcinoma of the nasopharynx. Oncology Forum, 6(1), 10-13.Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. (Journal article)
Chan, A. S. C., To, K. F., Lo, K. W., Ding, M., Li, X., Johnson, P., & Huang, D. P. (2002). Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese.. International journal of cancer, 102(3), 300-303. doi:10.1002/ijc.10689Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. (Journal article)
Chan, A. T. C., Lo, Y. M. D., Zee, B., Chan, L. Y. S., Ma, B. B. Y., Leung, S. -F., . . . Johnson, P. J. (2002). Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.. Journal of the National Cancer Institute, 94(21), 1614-1619. doi:10.1093/jnci/94.21.1614Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma. (Journal article)
Wong, N., Li, L., Tsang, K., Lai, P. B. -S., To, K. -F., & Johnson, P. J. (2002). Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma.. Journal of hepatology, 37(5), 633-639. doi:10.1016/s0168-8278(02)00269-6High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. (Journal article)
Chow, P. K. H., Tai, B. -C., Tan, C. -K., Machin, D., Win, K. M., Johnson, P. J., . . . Asian-Pacific Hepatocellular Carcinoma Trials Group. (2002). High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.. Hepatology (Baltimore, Md.), 36(5), 1221-1226. doi:10.1053/jhep.2002.36824Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma. (Journal article)
Leung, T. H. -Y., Wong, N., Lai, P. B. -S., Chan, A., To, K. -F., Liew, C. -T., . . . Johnson, P. J. (2002). Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 15(11), 1213-1220. doi:10.1097/01.mp.0000036347.66943.3cA Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma. (Journal article)
Mok, T. S. K., Wong, H., Zee, B., Yu, K. H., Leung, T. W. T., Lee, T. W., . . . Johnson, P. (2002). A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.. Cancer, 95(7), 1511-1519. doi:10.1002/cncr.10836Hepatocellular carcinoma: is current therapy really altering outcome? (Journal article)
Johnson, P. J. (2002). Hepatocellular carcinoma: is current therapy really altering outcome?. Gut, 51(4), 459-462. doi:10.1136/gut.51.4.459Nasopharyngeal carcinoma. (Journal article)
Chan, A. T. C., Teo, P. M. L., & Johnson, P. J. (2002). Nasopharyngeal carcinoma.. Annals of oncology : official journal of the European Society for Medical Oncology, 13(7), 1007-1015. doi:10.1093/annonc/mdf179Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma. (Journal article)
Chan, J. Y. H., Meng, C. L., To, K. F., Leung, S. F., Chan, A. T. C., Lee, K. K. H., & Johnson, P. J. (2002). Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma.. European journal of cancer (Oxford, England : 1990), 38(12), 1600-1606. doi:10.1016/s0959-8049(02)00080-1Plasma nucleic acids in the diagnosis and management of malignant disease. (Journal article)
Johnson, P. J., & Lo, Y. M. D. (2002). Plasma nucleic acids in the diagnosis and management of malignant disease.. Clinical chemistry, 48(8), 1186-1193.Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. (Journal article)
Ng, E. K. O., Tsui, N. B. Y., Lam, N. Y. L., Chiu, R. W. K., Yu, S. C. H., Wong, S. C. C., . . . Lo, Y. M. D. (2002). Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.. Clinical chemistry, 48(8), 1212-1217.Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein. (Journal article)
Poon, T. C. W., Mok, T. S. K., Chan, A. T. C., Chan, C. M. L., Leong, V., Tsui, S. H. T., . . . Johnson, P. J. (2002). Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.. Clinical chemistry, 48(7), 1021-1027.Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients. (Journal article)
Whitney, B. M., Chan, A. T. C., Rickinson, A. B., Lee, S. P., Lin, C. K., & Johnson, P. J. (2002). Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.. Journal of medical virology, 67(3), 359-363. doi:10.1002/jmv.10073Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer -- a retrospective review of Chinese patients and comparison with an historic Western series. (Journal article)
Ma, B., Yeo, W., Hui, P., Ho, W. M., & Johnson, P. J. (2002). Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer -- a retrospective review of Chinese patients and comparison with an historic Western series.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 62(2), 185-189. doi:10.1016/s0167-8140(02)00003-8Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. (Journal article)
Chan, A. T. C., Teo, P. M. L., Ngan, R. K., Leung, T. W., Lau, W. H., Zee, B., . . . Johnson, P. J. (2002). Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20(8), 2038-2044. doi:10.1200/jco.2002.08.149Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. (Journal article)
Zhong, S., Tang, M. W., Yeo, W., Liu, C., Lo, Y. M. D., & Johnson, P. J. (2002). Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(4), 1087-1092.Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. (Journal article)
Leung, T. W. T., Tang, A. M. Y., Zee, B., Lau, W. Y., Lai, P. B. S., Leung, K. L., . . . Johnson, P. J. (2002). Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.. Cancer, 94(6), 1760-1769. doi:10.1002/cncr.10384Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. (Journal article)
Lei, K. I. K., Chan, L. Y. S., Chan, W. -Y., Johnson, P. J., & Lo, Y. M. D. (2002). Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(1), 29-34.Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. (Journal article)
Kwong, J., Lo, K. -W., To, K. -F., Teo, P. M. L., Johnson, P. J., & Huang, D. P. (2002). Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(1), 131-137.Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines. (Journal article)
Pang, E., Wong, N., Lai, P. B. -S., To, K. -F., Lau, W. -Y., & Johnson, P. J. (2002). Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines.. Genes, chromosomes & cancer, 33(2), 150-159. doi:10.1002/gcc.1220Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy. (Journal article)
Leung, T. W. T., Tang, A. M. Y., Zee, B., Yu, S. C. H., Lai, P. B. S., Lau, W. Y., & Johnson, P. J. (2002). Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.. Cancer, 94(2), 421-427. doi:10.1002/cncr.10236Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. (Journal article)
Hui, E. P., Chan, A. T. C., Pezzella, F., Turley, H., To, K. -F., Poon, T. C. W., . . . Harris, A. L. (2002). Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(8), 2595-2604.Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients. (Journal article)
Zhong, S., Yeo, W., Tang, M., Liu, C., Lin, X. -R., Ho, W. M., . . . Johnson, P. J. (2002). Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients.. Journal of medical virology, 66(3), 428-434. doi:10.1002/jmv.2163Introduction: nasopharyngeal cancer (Conference Paper)
Huang, D. P., & Johnson, P. J. (2002). Introduction: nasopharyngeal cancer. In Seminars in Cancer Biology Vol. 12 (pp. 419). Elsevier BV. doi:10.1016/s1044579x02000846Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer. (Journal article)
Yeo, W., Mok, T. S. K., Tse, K. K., Kwan, W. H., Lam, K. C., Ho, W. M., . . . Johnson, P. J. (2002). Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.. Anti-cancer drugs, 13(6), 655-662. doi:10.1097/00001813-200207000-00013Screening for hepatocellular carcinoma--answers to some simple questions. (Journal article)
Johnson, P. J. (2002). Screening for hepatocellular carcinoma--answers to some simple questions.. The American journal of gastroenterology, 97(2), 225-226. doi:10.1111/j.1572-0241.2002.05448.xThe molecular biology of hepatitis B virus-associated hepatocellular carcinoma (Journal article)
Johnson, P. J. (2002). The molecular biology of hepatitis B virus-associated hepatocellular carcinoma. Unknown Journal, 101-111. doi:10.1016/s0168-7069(02)06069-x2001
Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma. (Journal article)
Poon, T. C., Chan, A. T., Zee, B., Ho, S. K., Mok, T. S., Leung, T. W., & Johnson, P. J. (2001). Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.. Oncology, 61(4), 275-283. doi:10.1159/000055334Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing. (Conference Paper)
Tang, N. L., Choy, K. W., Pang, C. P., Yeo, W., & Johnson, P. J. (2001). Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing.. In Clinica chimica acta; international journal of clinical chemistry Vol. 313 (pp. 179-185). doi:10.1016/s0009-8981(01)00671-4Proteome analysis and its impact on the discovery of serological tumor markers. (Conference Paper)
Poon, T. C., & Johnson, P. J. (2001). Proteome analysis and its impact on the discovery of serological tumor markers.. In Clinica chimica acta; international journal of clinical chemistry Vol. 313 (pp. 231-239). doi:10.1016/s0009-8981(01)00677-5Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis. (Journal article)
Yeo, W., Chan, P. K., Chan, H. L., Mo, F. K., & Johnson, P. J. (2001). Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis.. Journal of medical virology, 65(3), 473-477. doi:10.1002/jmv.2060Quantitative and genotypic analysis of TT virus infection in Chinese blood donors. (Journal article)
Zhong, S., Yeo, W., Lin, C. K., Lin, X. R., Tang, M. W., & Johnson, P. J. (2001). Quantitative and genotypic analysis of TT virus infection in Chinese blood donors.. Transfusion, 41(8), 1001-1007. doi:10.1046/j.1537-2995.2001.41081001.xThe use of brush cytology and directed biopsies for the detection of nasopharyngeal carcinoma and precursor lesions. (Journal article)
Chang, A. R., Liang, X. M., Chan, A. T., Chan, M. K., Teo, P. M., & Johnson, P. J. (2001). The use of brush cytology and directed biopsies for the detection of nasopharyngeal carcinoma and precursor lesions.. Head & neck, 23(8), 637-645. doi:10.1002/hed.1090Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation. (Journal article)
Wong, I. H., Yeo, W., Leung, T., Lau, W. Y., & Johnson, P. J. (2001). Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.. Cancer letters, 167(2), 183-191. doi:10.1016/s0304-3835(01)00455-4Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma. (Journal article)
Mok, T. S., Kanekal, S., Lin, X. R., Leung, T. W., Chan, A. T., Yeo, W., . . . Johnson, P. (2001). Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.. Cancer, 91(12), 2369-2377. doi:3.0.co;2-3">10.1002/1097-0142(20010615)91:12<2369::aid-cncr1270>3.0.co;2-3DOI: 10.1002/1097-0142(20010615)91:12<2369::aid-cncr1270>3.0.co;2-3
HLA class II alleles in Chinese patients with hepatocellular carcinoma. (Journal article)
Donaldson, P. T., Ho, S., Williams, R., & Johnson, P. J. (2001). HLA class II alleles in Chinese patients with hepatocellular carcinoma.. Liver, 21(2), 143-148. doi:10.1034/j.1600-0676.2001.021002143.xHigh frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. (Journal article)
Lo, K. W., Kwong, J., Hui, A. B., Chan, S. Y., To, K. F., Chan, A. S., . . . Huang, D. P. (2001). High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.. Cancer research, 61(10), 3877-3881.What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres? (Journal article)
Lau, W. Y., Ho, S., Leung, W. T., Chan, M., Lee, W. Y., & Johnson, P. J. (2001). What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres?. Hepato-gastroenterology, 48(38), 338-340.Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression. (Journal article)
Wong, I. H., Yeo, W., Chan, A. T., & Johnson, P. J. (2001). Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression.. Cancer letters, 162(1), 65-73. doi:10.1016/s0304-3835(00)00630-3A framework for the molecular classification of circulating tumor markers. (Conference Paper)
Johnson, P. J. (2001). A framework for the molecular classification of circulating tumor markers.. In Annals of the New York Academy of Sciences Vol. 945 (pp. 8-21). doi:10.1111/j.1749-6632.2001.tb03859.xCirculating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies. (Conference Paper)
Lei, K. I., Chan, L. Y., Chan, W. Y., Johnson, P. J., & Lo, Y. M. (2001). Circulating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies.. In Annals of the New York Academy of Sciences Vol. 945 (pp. 80-83). doi:10.1111/j.1749-6632.2001.tb03867.xCross-cultural validation of the McGill Quality of Life questionnaire in Hong Kong Chinese. (Journal article)
Lo, R. S., Woo, J., Zhoc, K. C., Li, C. Y., Yeo, W., Johnson, P., . . . Lee, J. (2001). Cross-cultural validation of the McGill Quality of Life questionnaire in Hong Kong Chinese.. Palliative medicine, 15(5), 387-397. doi:10.1191/026921601680419438Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring. (Conference Paper)
Wong, I. H., Lo, Y. M., & Johnson, P. J. (2001). Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring.. In Annals of the New York Academy of Sciences Vol. 945 (pp. 36-50).Genetic imbalances in pT2 breast cancers of southern Chinese women. (Journal article)
Fung, L. F., Wong, N., Tang, N., Lau, A., Wong, V., Pang, C. P., . . . Johnson, P. J. (2001). Genetic imbalances in pT2 breast cancers of southern Chinese women.. Cancer genetics and cytogenetics, 124(1), 56-61. doi:10.1016/s0165-4608(00)00328-9Gross elevation of TT virus genome load in the peripheral blood mononuclear cells of cancer patients. (Conference Paper)
Zhong, S., Yeo, W., Tang, M. W., Lin, X. R., Mo, F., Ho, W. M., . . . Johnson, P. J. (2001). Gross elevation of TT virus genome load in the peripheral blood mononuclear cells of cancer patients.. In Annals of the New York Academy of Sciences Vol. 945 (pp. 84-92). doi:10.1111/j.1749-6632.2001.tb03868.xHypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. (Journal article)
Wong, N., Lam, W. C., Lai, P. B., Pang, E., Lau, W. Y., & Johnson, P. J. (2001). Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.. The American journal of pathology, 159(2), 465-471. doi:10.1016/s0002-9440(10)61718-xManagement of hepatoma using cisplatin/epinephrine gel in patients awaiting orthotopic liver transplantation. (Journal article)
Thuluvath, P. J., Geschwind, J. F., Johnson, P. J., Heneghan, M. A., & O'Grady, J. (2001). Management of hepatoma using cisplatin/epinephrine gel in patients awaiting orthotopic liver transplantation.. Transplantation proceedings, 33(1-2), 1359-1360. doi:10.1016/s0041-1345(00)02510-0Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications. (Journal article)
Wong, I. H., Yeo, W., Chan, A. T., & Johnson, P. J. (2001). Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications.. International journal of oncology, 18(3), 633-638. doi:10.3892/ijo.18.3.633Systemic therapy for hepatocellular carcinoma. (Journal article)
Leung, T. W., & Johnson, P. J. (2001). Systemic therapy for hepatocellular carcinoma.. Seminars in oncology, 28(5), 514-520. doi:10.1016/s0093-7754(01)90144-7The cost of palliative care for hepatocellular carcinoma in Hong Kong. (Journal article)
Chan, A. T., Jacobs, P., Yeo, W., Lai, M., Hazlett, C. B., Mok, T. S., . . . Johnson, P. J. (2001). The cost of palliative care for hepatocellular carcinoma in Hong Kong.. PharmacoEconomics, 19(9), 947-953. doi:10.2165/00019053-200119090-00006The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. (Journal article)
Johnson, P. J. (2001). The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma.. Clinics in liver disease, 5(1), 145-159. doi:10.1016/s1089-3261(05)70158-62000
Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. (Journal article)
Lo, Y. M., Chan, A. T., Chan, L. Y., Leung, S. F., Lam, C. W., Huang, D. P., & Johnson, P. J. (2000). Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.. Cancer research, 60(24), 6878-6881.Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy. (Journal article)
Yeo, W., Zhong, S., Chan, P. K., Ho, W. M., Wong, H. T., Chan, A. S., & Johnson, P. J. (2000). Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy.. Journal of viral hepatitis, 7(6), 448-458. doi:10.1046/j.1365-2893.2000.00257.xFinal report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. (Journal article)
Teo, P. M., Leung, S. F., Chan, A. T., Leung, T. W., Choi, P. H., Kwan, W. H., . . . Johnson, P. J. (2000). Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.. International journal of radiation oncology, biology, physics, 48(5), 1311-1322. doi:10.1016/s0360-3016(00)00786-0Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. (Journal article)
Lei, K. I., Chan, L. Y., Chan, W. Y., Johnson, P. J., & Lo, Y. M. (2000). Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies.. British journal of haematology, 111(1), 239-246. doi:10.1046/j.1365-2141.2000.02344.xFrequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. (Journal article)
Yeo, W., Chan, P. K., Zhong, S., Ho, W. M., Steinberg, J. L., Tam, J. S., . . . Johnson, P. J. (2000). Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.. Journal of medical virology, 62(3), 299-307. doi:3.0.co;2-0">10.1002/1096-9071(200011)62:3<299::aid-jmv1>3.0.co;2-0Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. (Journal article)
Wong, I. H., Lo, Y. M., Yeo, W., Lau, W. Y., & Johnson, P. J. (2000). Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.. Clinical cancer research : an official journal of the American Association for Cancer Research, 6(9), 3516-3521.The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas. (Journal article)
Lei, K. I., & Johnson, P. J. (2000). The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas.. Cancer, 89(6), 1387-1395. doi:3.0.co;2-3">10.1002/1097-0142(20000915)89:6<1387::aid-cncr24>3.0.co;2-3DOI: 10.1002/1097-0142(20000915)89:6<1387::aid-cncr24>3.0.co;2-3
Alpha-fetoprotein variants in a case of pancreatoblastoma. (Journal article)
Chan, M. H., Shing, M. M., Poon, T. C., Johnson, P. J., & Lam, C. W. (2000). Alpha-fetoprotein variants in a case of pancreatoblastoma.. Annals of clinical biochemistry, 37 ( Pt 5), 681-685. doi:10.1258/0004563001899942Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients. (Journal article)
Wong, I. H., Lo, Y. M., Lai, P. B., & Johnson, P. J. (2000). Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.. Clinical chemistry, 46(9), 1420-1422.Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. (Journal article)
Wong, I. H., Lau, W. Y., Leung, T., & Johnson, P. J. (2000). Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring.. Cancer letters, 156(2), 141-149. doi:10.1016/s0304-3835(00)00473-0A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma. (Journal article)
Mok, T. S., Zee, B., Chan, A. T., Yeo, W., Yang, W. T., Yim, A., . . . Johnson, P. (2000). A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.. Cancer, 89(3), 543-550. doi:3.0.co;2-v">10.1002/1097-0142(20000801)89:3<543::aid-cncr9>3.0.co;2-vDOI: 10.1002/1097-0142(20000801)89:3<543::aid-cncr9>3.0.co;2-v
CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells. (Journal article)
Lee, S. P., Chan, A. T., Cheung, S. T., Thomas, W. A., CroomCarter, D., Dawson, C. W., . . . Huang, D. P. (2000). CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells.. Journal of immunology (Baltimore, Md. : 1950), 165(1), 573-582. doi:10.4049/jimmunol.165.1.573Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus. (Journal article)
Zhong, S., Ng, M. C., Lo, Y. M., Chan, J. C., & Johnson, P. J. (2000). Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus.. Journal of clinical pathology, 53(6), 466-469. doi:10.1136/jcp.53.6.466Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study. (Journal article)
Wong, I. H., Chan, A. T., & Johnson, P. J. (2000). Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study.. Clinical cancer research : an official journal of the American Association for Cancer Research, 6(6), 2183-2188.Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. (Journal article)
Lo, Y. M., Leung, S. F., Chan, L. Y., Chan, A. T., Lo, K. W., Johnson, P. J., & Huang, D. P. (2000). Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma.. Cancer research, 60(9), 2351-2355.Chemotherapy for Unresectable Liver Cancer (Conference Paper)
Johnson, P. J. (2000). Chemotherapy for Unresectable Liver Cancer. In Asian Journal of Surgery Vol. 23 (pp. 9). Springer Science and Business Media LLC. doi:10.1007/s101160050003Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues. (Journal article)
Zhong, S., Chan, J. Y., Yeo, W., Tam, J. S., & Johnson, P. J. (2000). Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues.. Journal of viral hepatitis, 7(2), 115-123. doi:10.1046/j.1365-2893.2000.00209.xLack of expression for the suppressor PML in human small cell lung carcinoma. (Journal article)
Zhang, P., Chin, W., Chow, L. T., Chan, A. S., Yim, A. P., Leung, S. F., . . . Chan, J. Y. (2000). Lack of expression for the suppressor PML in human small cell lung carcinoma.. International journal of cancer, 85(5), 599-605. doi:3.0.co;2-#">10.1002/(sici)1097-0215(20000301)85:5<599::aid-ijc1>3.0.co;2-#DOI: 10.1002/(sici)1097-0215(20000301)85:5<599::aid-ijc1>3.0.co;2-#
Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role. (Journal article)
Steinberg, J. L., Yeo, W., Zhong, S., Chan, J. Y., Tam, J. S., Chan, P. K., . . . Johnson, P. J. (2000). Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.. Journal of medical virology, 60(3), 249-255. doi:3.0.co;2-c">10.1002/(sici)1096-9071(200003)60:3<249::aid-jmv1>3.0.co;2-cDOI: 10.1002/(sici)1096-9071(200003)60:3<249::aid-jmv1>3.0.co;2-c
Novel intertypic recombinants of epstein-barr virus in the chinese population. (Journal article)
Midgley, R. S., Blake, N. W., Yao, Q. Y., Croom-Carter, D., Cheung, S. T., Leung, S. F., . . . Lee, S. P. (2000). Novel intertypic recombinants of epstein-barr virus in the chinese population.. Journal of virology, 74(3), 1544-1548. doi:10.1128/jvi.74.3.1544-1548.2000A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization. (Journal article)
Pang, E., Wong, N., Lai, P. B., To, K. F., Lau, J. W., & Johnson, P. J. (2000). A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization.. Cancer genetics and cytogenetics, 121(1), 9-16. doi:10.1016/s0165-4608(99)00247-2Chromosomal translocations are common in natural killer-cell lymphoma/leukemia as shown by spectral karyotyping. (Journal article)
Wong, N., Wong, K. F., Chan, J. K., & Johnson, P. J. (2000). Chromosomal translocations are common in natural killer-cell lymphoma/leukemia as shown by spectral karyotyping.. Human pathology, 31(6), 771-774. doi:10.1053/hupa.2000.7625Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. (Conference Paper)
Fan, C. S., Wong, N., Leung, S. F., To, K. F., Lo, K. W., Lee, S. W., . . . Huang, D. P. (2000). Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma.. In Human pathology Vol. 31 (pp. 169-178). doi:10.1016/s0046-8177(00)80216-6Genomic aberrations in human hepatocellular carcinomas of differing etiologies. (Journal article)
Wong, N., Lai, P., Pang, E., Fung, L. F., Sheng, Z., Wong, V., . . . Johnson, P. J. (2000). Genomic aberrations in human hepatocellular carcinomas of differing etiologies.. Clinical cancer research : an official journal of the American Association for Cancer Research, 6(10), 4000-4009.Hepatocellular carcinoma and the art of prognostication. (Journal article)
Johnson, P., & Bruix, J. (2000). Hepatocellular carcinoma and the art of prognostication.. Journal of hepatology, 33(6), 1006-1008. doi:10.1016/s0168-8278(00)80137-3Molecular analysis of circulating tumor cells in peripheral blood from patients with germ cell tumor: a quantitative approach. (Journal article)
Wong, I. H., Chan, A. T., & Johnson, P. J. (2000). Molecular analysis of circulating tumor cells in peripheral blood from patients with germ cell tumor: a quantitative approach.. International journal of molecular medicine, 6(4), 491-494. doi:10.3892/ijmm.6.4.491Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging. (Conference Paper)
Lo, Y. M., Leung, S. F., Chan, L. Y., Lo, K. W., Zhang, J., Chan, A. T., . . . Huang, D. P. (2000). Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging.. In Annals of the New York Academy of Sciences Vol. 906 (pp. 99-101). doi:10.1111/j.1749-6632.2000.tb06597.xRadiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management. (Journal article)
Yeo, W., & Johnson, P. J. (2000). Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management.. American journal of clinical dermatology, 1(2), 113-116. doi:10.2165/00128071-200001020-00006Structures of disease-specific serum alpha-fetoprotein isoforms. (Journal article)
Johnson, P. J., Poon, T. C., Hjelm, N. M., Ho, C. S., Blake, C., & Ho, S. K. (2000). Structures of disease-specific serum alpha-fetoprotein isoforms.. British journal of cancer, 83(10), 1330-1337. doi:10.1054/bjoc.2000.1441TT virus: a study of molecular epidemiology and transmission of genotypes 1, 2 and 3. (Journal article)
Gallian, P., Biagini, P., Zhong, S., Touinssi, M., Yeo, W., Cantaloube, J. F., . . . de Lamballerie, X. (2000). TT virus: a study of molecular epidemiology and transmission of genotypes 1, 2 and 3.. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 17(1), 43-49. doi:10.1016/s1386-6532(00)00066-4Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients. Implications for cancer detection and monitoring. (Conference Paper)
Wong, I. H., Johnson, P. J., Lai, P. B., Lau, W. Y., & Lo, Y. M. (2000). Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients. Implications for cancer detection and monitoring.. In Annals of the New York Academy of Sciences Vol. 906 (pp. 102-105). doi:10.1111/j.1749-6632.2000.tb06598.x1999
Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. (Journal article)
Wong, I. H., Lau, W. Y., Leung, T., Yeo, W., & Johnson, P. J. (1999). Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.. Clinical cancer research : an official journal of the American Association for Cancer Research, 5(12), 4021-4027.Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. (Journal article)
Lo, Y. M., Chan, L. Y., Chan, A. T., Leung, S. F., Lo, K. W., Zhang, J., . . . Huang, D. P. (1999). Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.. Cancer research, 59(21), 5452-5455.Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy. (Journal article)
Yeo, W., Steinberg, J. L., Tam, J. S., Chan, P. K., Leung, N. W., Lam, K. C., . . . Johnson, P. J. (1999). Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.. Journal of medical virology, 59(3), 263-269. doi:3.0.co;2-x">10.1002/(sici)1096-9071(199911)59:3<263::aid-jmv1>3.0.co;2-xDOI: 10.1002/(sici)1096-9071(199911)59:3<263::aid-jmv1>3.0.co;2-x
A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma. (Journal article)
Mok, T. S., Leung, T. W., Lee, S. D., Chao, Y., Chan, A. T., Huang, A., . . . Johnson, P. (1999). A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.. Cancer chemotherapy and pharmacology, 44(4), 307-311. doi:10.1007/s002800050982Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. (Journal article)
Lo, K. W., Lo, Y. M., Leung, S. F., Tsang, Y. S., Chan, L. Y., Johnson, P. J., . . . Huang, D. P. (1999). Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma.. Clinical chemistry, 45(8 Pt 1), 1292-1294.Translocation (5;19)(q33;q13) as the sole abnormality in a case of refractory anemia with excess of blasts in transformation. (Journal article)
Wong, N., Yeo, W., Yuen, J., & Johnson, P. J. (1999). Translocation (5;19)(q33;q13) as the sole abnormality in a case of refractory anemia with excess of blasts in transformation.. Cancer genetics and cytogenetics, 112(2), 186-187. doi:10.1016/s0165-4608(98)00270-2Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. (Journal article)
Leung, T. W., Patt, Y. Z., Lau, W. Y., Ho, S. K., Yu, S. C., Chan, A. T., . . . Johnson, P. J. (1999). Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 5(7), 1676-1681.Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes. (Journal article)
Yeo, W., Chan, K. K., Mukwaya, G., Ross, M., Leung, W. T., Ho, S., . . . Johnson, P. J. (1999). Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes.. Cancer chemotherapy and pharmacology, 44(2), 124-130. doi:10.1007/s002800050956Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. (Journal article)
Tang, N. L., Pang, C. P., Yeo, W., Choy, K. W., Lam, P. K., Suen, M., . . . Hjelm, M. (1999). Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer.. Journal of the National Cancer Institute, 91(10), 882-885. doi:10.1093/jnci/91.10.882Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues. (Journal article)
Zhong, S., Chan, J. Y., Yeo, W., Tam, J. S., & Johnson, P. J. (1999). Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.. Journal of viral hepatitis, 6(3), 195-202. doi:10.1046/j.1365-2893.1999.00154.xQuantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. (Journal article)
Lo, Y. M., Chan, L. Y., Lo, K. W., Leung, S. F., Zhang, J., Chan, A. T., . . . Huang, D. P. (1999). Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.. Cancer research, 59(6), 1188-1191.Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. (Journal article)
Lau, W. Y., Leung, T. W., Ho, S. K., Chan, M., Machin, D., Lau, J., . . . Johnson, P. J. (1999). Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.. Lancet (London, England), 353(9155), 797-801. doi:10.1016/s0140-6736(98)06475-7Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma--the possibility of radiation carcinogenesis. (Journal article)
Teo, P. M., Chan, A. T., Leung, S. F., Chau, R. M., Yu, P. K., King, W. W., & Johnson, P. J. (1999). Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma--the possibility of radiation carcinogenesis.. European journal of cancer (Oxford, England : 1990), 35(2), 219-225. doi:10.1016/s0959-8049(98)00386-4Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. (Journal article)
Teo, P. M., Chan, A. T., Lee, W. Y., Leung, T. W., & Johnson, P. J. (1999). Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.. International journal of radiation oncology, biology, physics, 43(2), 261-271. doi:10.1016/s0360-3016(98)00383-6Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. (Journal article)
Wong, N., Lai, P., Lee, S. W., Fan, S., Pang, E., Liew, C. T., . . . Johnson, P. J. (1999). Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.. The American journal of pathology, 154(1), 37-43. doi:10.1016/s0002-9440(10)65248-0Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21. (Journal article)
Su, X. Y., Wong, N., Cao, Q., Yu, L. Z., Niu, C., Wickham, N., . . . Chen, S. J. (1999). Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.. Cancer genetics and cytogenetics, 108(1), 6-12. doi:10.1016/s0165-4608(98)00120-4Combating hepatocellular carcinoma with an integrated approach. (Journal article)
Ho, S., Johnson, P. J., Leung, W. T., & Lau, W. Y. (1999). Combating hepatocellular carcinoma with an integrated approach.. Chinese medical journal, 112(1), 80-83.Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. (Journal article)
Wong, I. H., Lo, Y. M., Zhang, J., Liew, C. T., Ng, M. H., Wong, N., . . . Johnson, P. J. (1999). Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.. Cancer research, 59(1), 71-73.Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour. (Journal article)
Johnson, P. J., Poon, T. C., Hjelm, N. M., Ho, C. S., Ho, S. K., Welby, C., . . . Townsend, R. R. (1999). Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.. British journal of cancer, 81(7), 1188-1195. doi:10.1038/sj.bjc.6690828Monitoring response to treatment in liver tumours. (Journal article)
Yang, W. T., & Johnson, P. J. (1999). Monitoring response to treatment in liver tumours.. Bailliere's best practice & research. Clinical gastroenterology, 13(4), 637-654. doi:10.1053/bega.1999.0053Preface (Journal article)
Johnson, P. J. (1999). Preface. Best Practice & Research Clinical Gastroenterology, 13(4), vii-viii. doi:10.1053/bega.1999.0043Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. (Journal article)
Johnson, P. J. (1999). Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.. Journal of gastroenterology and hepatology, 14 Suppl, S32-S36. doi:10.1046/j.1440-1746.1999.01873.x1998
A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma. (Journal article)
Yeo, W., Leung, T. W., Chan, A. T., Chiu, S. K., Yu, P., Mok, T. S., & Johnson, P. J. (1998). A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma.. European journal of cancer (Oxford, England : 1990), 34(13), 2027-2031. doi:10.1016/s0959-8049(98)00280-9Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review. (Journal article)
Ho, S., Lau, W. Y., Leung, T. W., & Johnson, P. J. (1998). Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review.. Cancer, 83(9), 1894-1907. doi:3.0.co;2-o">10.1002/(sici)1097-0142(19981101)83:9<1894::aid-cncr4>3.0.co;2-oDOI: 10.1002/(sici)1097-0142(19981101)83:9<1894::aid-cncr4>3.0.co;2-o
Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year period. (Journal article)
Ho, S., Teo, P., Kwan, W. H., Choi, P., Tjong, J., & Johnson, P. J. (1998). Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year period.. Oral oncology, 34(6), 491-495. doi:10.1016/s1368-8375(98)00063-3Multimodality treatment of primary lymphoepithelioma-like carcinoma of the lung. (Journal article)
Chan, A. T., Teo, P. M., Lam, K. C., Chan, W. Y., Chow, J. H., Yim, A. P., . . . Johnson, P. J. (1998). Multimodality treatment of primary lymphoepithelioma-like carcinoma of the lung.. Cancer, 83(5), 925-929. doi:3.0.co;2-x">10.1002/(sici)1097-0142(19980901)83:5<925::aid-cncr18>3.0.co;2-xDOI: 10.1002/(sici)1097-0142(19980901)83:5<925::aid-cncr18>3.0.co;2-x
Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma. (Journal article)
Chan, A. T., Leung, T. W., Kwan, W. H., Mok, T. S., Yeo, W., Lai, M., & Johnson, P. J. (1998). Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma.. Cancer chemotherapy and pharmacology, 42(3), 247-249. doi:10.1007/s002800050812Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma. (Journal article)
Mok, T. S., Steinberg, J., Chan, A. T., Yeo, W. M., Hui, P., Leung, T. W., & Johnson, P. (1998). Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.. Cancer, 82(12), 2439-2448. doi:3.0.co;2-q">10.1002/(sici)1097-0142(19980615)82:12<2439::aid-cncr19>3.0.co;2-qDOI: 10.1002/(sici)1097-0142(19980615)82:12<2439::aid-cncr19>3.0.co;2-q
Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues. (Journal article)
Chan, J. Y., Chin, W., Liew, C. T., Chang, K. S., & Johnson, P. J. (1998). Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues.. European journal of cancer (Oxford, England : 1990), 34(7), 1015-1022. doi:10.1016/s0959-8049(97)10138-1Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis. (Journal article)
Ho, S., & Johnson, P. J. (1998). Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis.. British journal of cancer, 77(11), 2059. doi:10.1038/bjc.1998.344Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. (Journal article)
Cheung, S. T., Leung, S. F., Lo, K. W., Chiu, K. W., Tam, J. S., Fok, T. F., . . . Huang, D. P. (1998). Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.. International journal of cancer, 76(3), 399-406. doi:3.0.co;2-6">10.1002/(sici)1097-0215(19980504)76:3<399::aid-ijc18>3.0.co;2-6DOI: 10.1002/(sici)1097-0215(19980504)76:3<399::aid-ijc18>3.0.co;2-6
Detection of chromosome over- and underrepresentations in hyperdiploid acute lymphoblastic leukemia by comparative genomic hybridization. (Journal article)
Wong, N., Chen, S. J., Cao, Q., Su, X. Y., Niu, C., Wu, Q. W., . . . Chen, Z. (1998). Detection of chromosome over- and underrepresentations in hyperdiploid acute lymphoblastic leukemia by comparative genomic hybridization.. Cancer genetics and cytogenetics, 103(1), 20-24. doi:10.1016/s0165-4608(97)00382-8The role of chemotherapy in the management of nasopharyngeal carcinoma. (Journal article)
Chan, A. T., Teo, P. M., Leung, T. W., & Johnson, P. J. (1998). The role of chemotherapy in the management of nasopharyngeal carcinoma.. Cancer, 82(6), 1003-1012. doi:3.0.co;2-f">10.1002/(sici)1097-0142(19980315)82:6<1003::aid-cncr1>3.0.co;2-fDOI: 10.1002/(sici)1097-0142(19980315)82:6<1003::aid-cncr1>3.0.co;2-f
Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. (Journal article)
Lau, W. Y., Ho, S., Leung, T. W., Chan, M., Ho, R., Johnson, P. J., & Li, A. K. (1998). Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.. International journal of radiation oncology, biology, physics, 40(3), 583-592. doi:10.1016/s0360-3016(97)00818-3Controversies in the management of locoregionally advanced nasopharyngeal carcinoma. (Journal article)
Chan, A. T., Teo, P. M., & Johnson, P. J. (1998). Controversies in the management of locoregionally advanced nasopharyngeal carcinoma.. Current opinion in oncology, 10(3), 219-225. doi:10.1097/00001622-199805000-00008Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate. (Journal article)
Sung, J. J., Yeo, W., Suen, R., Lee, Y. T., Chung, S. C., Chan, F. K., & Johnson, P. J. (1998). Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.. Gastrointestinal endoscopy, 47(3), 235-239. doi:10.1016/s0016-5107(98)70319-0New treatment for hepatocellular carcinoma. (Journal article)
Johnson, P. J. (1998). New treatment for hepatocellular carcinoma.. Journal of gastroenterology and hepatology, 13(S3), S311-S314. doi:10.1111/j.1440-1746.1998.tb01900.xQuantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. (Journal article)
Lo, Y. M., Tein, M. S., Lau, T. K., Haines, C. J., Leung, T. N., Poon, P. M., . . . Hjelm, N. M. (1998). Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.. American journal of human genetics, 62(4), 768-775. doi:10.1086/301800The significance of keratinizing squamous cell histology in Chinese patients with nasopharyngeal carcinoma. (Journal article)
Chan, A. T., Teo, M. L., Lee, W. Y., Kwan, W. H., Choi, P. H., & Johnson, P. J. (1998). The significance of keratinizing squamous cell histology in Chinese patients with nasopharyngeal carcinoma.. Clinical oncology (Royal College of Radiologists (Great Britain)), 10(3), 161-164. doi:10.1016/s0936-6555(98)80057-51997
Arteriovenous shunts in patients with hepatic tumors. (Journal article)
Ho, S., Lau, W. Y., Leung, W. T., Chan, M., Chan, K. W., Johnson, P. J., & Li, A. K. (1997). Arteriovenous shunts in patients with hepatic tumors.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 38(8), 1201-1205.Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin. (Journal article)
Ho, S., Lau, W. Y., Leung, T. W., Chan, M., Chan, K. W., Lee, W. Y., . . . Li, A. K. (1997). Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.. The British journal of radiology, 70(836), 823-828. doi:10.1259/bjr.70.836.9486047Treatment of autoimmune hepatitis. (Journal article)
Johnson, P. J. (1997). Treatment of autoimmune hepatitis.. Gut, 41(1), 3-4. doi:10.1136/gut.41.1.3Chorionic villus sampling and early amniocentesis for prenatal diagnosis. (Journal article)
Johnson, P. (1997). Chorionic villus sampling and early amniocentesis for prenatal diagnosis.. Lancet (London, England), 349(9062), 1396. doi:10.1016/s0140-6736(05)63236-9Chorionic villus sampling and early amniocentesis for prenatal diagnosis. (Journal article)
Greenough, A., & Nicolaides, K. H. (1997). Chorionic villus sampling and early amniocentesis for prenatal diagnosis.. Lancet (London, England), 349(9062), 1395-1396. doi:10.1016/s0140-6736(05)63235-7Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. (Journal article)
Ho, S., Lau, W. Y., Leung, T. W., Chan, M., Johnson, P. J., & Li, A. K. (1997). Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer.. European journal of nuclear medicine, 24(3), 293-298. doi:10.1007/bf01728766'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. (Journal article)
Johnson, P. J., Leung, N., Cheng, P., Welby, C., Leung, W. T., Lau, W. Y., . . . Ho, S. (1997). 'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.. British journal of cancer, 75(2), 236-240. doi:10.1038/bjc.1997.39'Spontaneous' regression of advanced leiomyosarcoma of the urinary bladder. (Journal article)
Lei, K. I., Gwi, E., Ma, L., Liang, E. Y., & Johnson, P. J. (1997). 'Spontaneous' regression of advanced leiomyosarcoma of the urinary bladder.. Oncology, 54(1), 19-22. doi:10.1159/000227655Aggressive primary natural killer cell lymphoma of the caecum: a case report and literature review. (Journal article)
Lei, K. I., Chow, J. H., & Johnson, P. J. (1997). Aggressive primary natural killer cell lymphoma of the caecum: a case report and literature review.. Clinical oncology (Royal College of Radiologists (Great Britain)), 9(3), 191-194. doi:10.1016/s0936-6555(97)80081-7Assessment of proliferating cell nuclear antigen in nasopharyngeal carcinoma tissue and its relation to clinical findings. (Journal article)
Chan, A. T., Ho, S., Teo, P. M., Tjong, J., Choi, J., Lee, W. Y., . . . Johnson, P. J. (1997). Assessment of proliferating cell nuclear antigen in nasopharyngeal carcinoma tissue and its relation to clinical findings.. Oral oncology, 33(1), 13-18. doi:10.1016/s0964-1955(96)00029-2Carbamazepine-induced lymphadenopathy mimicking Ki-1 (CD30+) T-cell lymphoma. (Journal article)
Yeo, W., Chow, J., Wong, N., Chan, A. T., & Johnson, P. J. (1997). Carbamazepine-induced lymphadenopathy mimicking Ki-1 (CD30+) T-cell lymphoma.. Pathology, 29(1), 64-66. doi:10.1080/00313029700169564Cosmetic outcome of breast-conserving therapy in Chinese patients with early breast cancer. (Journal article)
Yeo, W., Kwan, W. H., Teo, P. M., Leung, W. T., King, W., & Johnson, P. J. (1997). Cosmetic outcome of breast-conserving therapy in Chinese patients with early breast cancer.. The Australian and New Zealand journal of surgery, 67(11), 771-774. doi:10.1111/j.1445-2197.1997.tb04577.xCyanoacrylate vs sodium tetradecyl sulphate for the injection of bleeding varices in patients with hepatocellular carcinoma: A prospective randomized study (Journal article)
Sung, J. Y., Yoe, W., Suen, R., Chan, K. L., Lee, Y. T., Chung, S. C. S., & Johnson, P. (1997). Cyanoacrylate vs sodium tetradecyl sulphate for the injection of bleeding varices in patients with hepatocellular carcinoma: A prospective randomized study. Gastrointestinal Endoscopy, 45(4), AB85. doi:10.1016/s0016-5107(97)80242-8Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia. (Journal article)
Mok, T., Koehler, A. P., Yu, M. Y., Ellis, D. H., Johnson, P. J., & Wickham, N. W. (1997). Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia.. Journal of clinical microbiology, 35(10), 2654-2656. doi:10.1128/jcm.35.10.2654-2656.1997Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. (Journal article)
Naoumov, N. V., Chokshi, S., Metivier, E., Maertens, G., Johnson, P. J., & Williams, R. (1997). Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis.. Journal of hepatology, 27(2), 331-336. doi:10.1016/s0168-8278(97)80179-1MRI and CT of metastatic hepatocellular carcinoma causing spinal cord compression. (Journal article)
Yang, W. T., Yeo, W., Leung, S. F., Chan, Y. L., Johnson, P. J., & Metreweli, C. (1997). MRI and CT of metastatic hepatocellular carcinoma causing spinal cord compression.. Clinical radiology, 52(10), 755-760. doi:10.1016/s0009-9260(97)80154-7Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold. (Journal article)
Yeo, W., Leung, S. F., & Johnson, P. J. (1997). Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold.. European journal of cancer (Oxford, England : 1990), 33(4), 698-699. doi:10.1016/s0959-8049(96)00461-3Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. (Journal article)
Wong, I. H., Leung, T., Ho, S., Lau, W. Y., Chan, M., & Johnson, P. J. (1997). Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.. British journal of cancer, 76(5), 628-633. doi:10.1038/bjc.1997.436Transdermal fentanyl for severe cancer-related pain. (Journal article)
Yeo, W., Lam, K. K., Chan, A. T., Leung, T. W., Nip, S. Y., & Johnson, P. J. (1997). Transdermal fentanyl for severe cancer-related pain.. Palliative medicine, 11(3), 233-239. doi:10.1177/0269216397011003081996
Serum levels of CYFRA 21-1 in nasopharyngeal carcinoma and its possible role in monitoring of therapy. (Journal article)
Ho, S., Leung, W. T., Yuen, J., & Johnson, P. J. (1996). Serum levels of CYFRA 21-1 in nasopharyngeal carcinoma and its possible role in monitoring of therapy.. European journal of cancer. Part B, Oral oncology, 32B(6), 377-380. doi:10.1016/s0964-1955(96)00017-6The epidemiology of hepatocellular carcinoma. (Journal article)
Johnson, P. J. (1996). The epidemiology of hepatocellular carcinoma.. European journal of gastroenterology & hepatology, 8(9), 845-849.Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. (Journal article)
Teo, P., Yu, P., Lee, W. Y., Leung, S. F., Kwan, W. H., Yu, K. H., . . . Johnson, P. J. (1996). Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.. International journal of radiation oncology, biology, physics, 36(2), 291-304. doi:10.1016/s0360-3016(96)00323-9Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma. (Journal article)
Yeo, W., Leung, T. W., Leung, S. F., Teo, P. M., Chan, A. T., Lee, W. Y., & Johnson, P. J. (1996). Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma.. Cancer chemotherapy and pharmacology, 38(5), 466-470. doi:10.1007/s002800050512Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. (Journal article)
Teo, P. M., Kwan, W. H., Lee, W. Y., Leung, S. F., & Johnson, P. J. (1996). Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma.. Cancer, 77(12), 2423-2431. doi:3.0.co;2-n">10.1002/(sici)1097-0142(19960615)77:12<2423::aid-cncr2>3.0.co;2-nDOI: 10.1002/(sici)1097-0142(19960615)77:12<2423::aid-cncr2>3.0.co;2-n
Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. (Journal article)
Cheung, S. T., Lo, K. W., Leung, S. F., Chan, W. Y., Choi, P. H., Johnson, P. J., . . . Huang, D. P. (1996). Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong.. International journal of cancer, 66(5), 711-712. doi:3.0.co;2-5">10.1002/(sici)1097-0215(19960529)66:5<711::aid-ijc21>3.0.co;2-5DOI: 10.1002/(sici)1097-0215(19960529)66:5<711::aid-ijc21>3.0.co;2-5
Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma. (Journal article)
Teo, P. M., Kwan, W. H., Leung, S. F., Leung, W. T., Chan, A., Choi, P., . . . Johnson, P. (1996). Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma.. The British journal of radiology, 69(819), 241-248. doi:10.1259/0007-1285-69-819-241Small cell variant of Ki-1 lymphoma associated with myelofibrosis and a novel constitutional chromosomal translocation t(3;4) (q13;q12). (Journal article)
Yeo, W., Wong, N., Chow, J., Tsoi, W. C., Johnson, P. J., & Wickham, N. (1996). Small cell variant of Ki-1 lymphoma associated with myelofibrosis and a novel constitutional chromosomal translocation t(3;4) (q13;q12).. Journal of clinical pathology, 49(3), 259-262. doi:10.1136/jcp.49.3.259Conservative surgery and radiotherapy for early-staged breast cancer (Journal article)
Kwan, W. H., Teo, P. M. L., Yeo, W., Yu, P., Choi, P. H. K., & Johnson, P. J. (1996). Conservative surgery and radiotherapy for early-staged breast cancer. Hong Kong Medical Journal, 2(1), 47-55.Hepatic angiomyelolipoma and tuberous sclerosis. (Journal article)
Yeo, W., Leong, A., Ward, S. C., Hui, P. K., & Johnson, P. J. (1996). Hepatic angiomyelolipoma and tuberous sclerosis.. Journal of gastroenterology and hepatology, 11(2), 196-198. doi:10.1111/j.1440-1746.1996.tb00061.xIn vitro uptake of bromodeoxyuridine by human nasopharyngeal carcinoma (NPC) and its relation to clinical findings. (Journal article)
Chan, A. T., Ho, S., Teo, P. M., Law, V., Tjong, J., Yu, P., . . . Johnson, P. J. (1996). In vitro uptake of bromodeoxyuridine by human nasopharyngeal carcinoma (NPC) and its relation to clinical findings.. European journal of cancer. Part B, Oral oncology, 32B(1), 50-54. doi:10.1016/0964-1955(95)00057-7Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels. (Journal article)
Ho, S., Cheng, P., Yuen, J., Chan, A., Leung, N., Yeo, W., . . . Johnson, P. J. (1996). Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.. British journal of cancer, 73(8), 985-988. doi:10.1038/bjc.1996.192Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive treatment. (Journal article)
Kwan, W. H., Teo, P. M., Chow, L. T., Choi, P. H., & Johnson, P. J. (1996). Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive treatment.. Clinical oncology (Royal College of Radiologists (Great Britain)), 8(1), 55-58. doi:10.1016/s0936-6555(05)80041-xNon-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. (Journal article)
Henk, J. M. (1996). Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices.. Clinical oncology (Royal College of Radiologists (Great Britain)), 8(2), 133. doi:10.1016/s0936-6555(96)80133-6Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. (Journal article)
Ho, S., Lau, W. Y., Leung, T. W., Chan, M., Ngar, Y. K., Johnson, P. J., & Li, A. K. (1996). Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.. European journal of nuclear medicine, 23(8), 947-952. doi:10.1007/bf01084369Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends. (Journal article)
Chan, A. T., Ho, S., Yim, A. P., Chang, A. R., Cheng, P., Yuen, J., . . . Johnson, P. J. (1996). Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.. Acta oncologica (Stockholm, Sweden), 35(2), 221-227. doi:10.3109/02841869609098505Strong association between hyperferritinaemia and metastatic disease in nasopharyngeal carcinoma. (Journal article)
Ho, S., Leung, S. F., Leung, W. T., Tsao, S. Y., Kwan, W. H., Choi, P., & Johnson, P. J. (1996). Strong association between hyperferritinaemia and metastatic disease in nasopharyngeal carcinoma.. European journal of cancer. Part B, Oral oncology, 32B(4), 242-245. doi:10.1016/0964-1955(95)00084-4Thromboembolic events with paclitaxel. (Journal article)
Chan, A. T., Yeo, W., Leung, W. T., & Johnson, P. J. (1996). Thromboembolic events with paclitaxel.. Clinical oncology (Royal College of Radiologists (Great Britain)), 8(2), 133. doi:10.1016/s0936-6555(96)80134-81995
A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma. (Journal article)
Yeo, W., Sung, J. Y., Ward, S. C., Chung, S. C., Lee, W. Y., Li, A. K., & Johnson, P. J. (1995). A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma.. Digestive diseases and sciences, 40(12), 2516-2521. doi:10.1007/bf02220435A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. (Journal article)
Chan, A. T., Teo, P. M., Leung, T. W., Leung, S. F., Lee, W. Y., Yeo, W., . . . Johnson, P. J. (1995). A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.. International journal of radiation oncology, biology, physics, 33(3), 569-577. doi:10.1016/0360-3016(95)00218-nAzathioprine for long-term maintenance of remission in autoimmune hepatitis. (Journal article)
Johnson, P. J., McFarlane, I. G., & Williams, R. (1995). Azathioprine for long-term maintenance of remission in autoimmune hepatitis.. The New England journal of medicine, 333(15), 958-963. doi:10.1056/nejm199510123331502Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies. (Journal article)
Lau, W. Y., Leung, W. T., Ho, S., Lam, S. K., Li, C. Y., Johnson, P. J., . . . Li, A. K. (1995). Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies.. Cancer, 75(11), 2669-2676. doi:3.0.co;2-b">10.1002/1097-0142(19950601)75:11<2669::aid-cncr2820751105>3.0.co;2-bDOI: 10.1002/1097-0142(19950601)75:11<2669::aid-cncr2820751105>3.0.co;2-b
Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. (Journal article)
Lin, J., Leung, W. T., Ho, S. K., Ho, K. C., Kumta, S. M., Metreweli, C., & Johnson, P. J. (1995). Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.. European journal of nuclear medicine, 22(6), 553-555. doi:10.1007/bf00817281Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing. (Journal article)
Johnson, P. J., Ho, S., Cheng, P., Chan, A., Leung, T., & Yuen, J. (1995). Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.. Cancer, 75(7), 1663-1668. doi:3.0.co;2-o">10.1002/1097-0142(19950401)75:7<1663::aid-cncr2820750717>3.0.co;2-oDOI: 10.1002/1097-0142(19950401)75:7<1663::aid-cncr2820750717>3.0.co;2-o
A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC). (Journal article)
Teo, P. M., Leung, T. W., Chan, A. T., Yu, P., Lee, W. Y., Leung, S. F., . . . Johnson, P. (1995). A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC).. European journal of cancer. Part B, Oral oncology, 31B(6), 373-379. doi:10.1016/0964-1955(95)00026-7Extraosseous osteogenic sarcoma of the mediastinum occurring in a Chinese patient. (Journal article)
Lin, J., Ho, J., Chan, A., Yeo, W., Yip, K. M., & Johnson, P. J. (1995). Extraosseous osteogenic sarcoma of the mediastinum occurring in a Chinese patient.. Clinical oncology (Royal College of Radiologists (Great Britain)), 7(3), 200-201. doi:10.1016/s0936-6555(05)80518-7Nonseminomatous germ cell tumour of testis in Hong Kong Chinese patients. (Journal article)
Chan, A. T., Cheung, M. C., Lau, W. H., Lin, J., Yeo, W., & Johnson, P. J. (1995). Nonseminomatous germ cell tumour of testis in Hong Kong Chinese patients.. Oncology, 52(3), 230-236. doi:10.1159/000227463Obstructive jaundice secondary to hepatocellular carcinoma. (Journal article)
Lau, W. Y., Leung, K. L., Leung, T. W., Ho, S., Chan, M., Liew, C. K., . . . Li, A. K. (1995). Obstructive jaundice secondary to hepatocellular carcinoma.. Surgical oncology, 4(6), 303-308. doi:10.1016/s0960-7404(10)80042-8Recombinant human erythropoietin for anaemia in Chinese cancer patients on chemotherapy. (Journal article)
Chan, A. T., Leung, W. T., Lin, J., Yeo, W., & Johnson, P. J. (1995). Recombinant human erythropoietin for anaemia in Chinese cancer patients on chemotherapy.. Clinical oncology (Royal College of Radiologists (Great Britain)), 7(4), 272. doi:10.1016/s0936-6555(05)80622-3Severe hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone in a patient receiving interferon-alpha for chronic myeloid leukemia. (Journal article)
Lei, K. I., Wickham, N. W., & Johnson, P. J. (1995). Severe hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone in a patient receiving interferon-alpha for chronic myeloid leukemia.. American journal of hematology, 49(1), 100. doi:10.1002/ajh.2830490123Why can't we cure primary liver cancer? (Journal article)
Johnson, P. J. (1995). Why can't we cure primary liver cancer?. European journal of cancer (Oxford, England : 1990), 31A(10), 1562-1564. doi:10.1016/0959-8049(95)00080-31994
Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activity. (Journal article)
Dobbs, N. A., Twelves, C. J., Rizzi, P., Warwick, J. D., Metivier, E. M., Williams, R., & Johnson, P. J. (1994). Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activity.. Cancer chemotherapy and pharmacology, 34(5), 405-410. doi:10.1007/bf00685565Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing. (Journal article)
Burditt, L. J., Johnson, M. M., Johnson, P. J., & Williams, R. (1994). Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing.. Cancer, 74(1), 25-29. doi:3.0.co;2-u">10.1002/1097-0142(19940701)74:1<25::aid-cncr2820740106>3.0.co;2-uDOI: 10.1002/1097-0142(19940701)74:1<25::aid-cncr2820740106>3.0.co;2-u
Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma. (Journal article)
Teo, P., Leung, S. F., Choi, P., Lee, W. Y., & Johnson, P. J. (1994). Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma.. The British journal of radiology, 67(794), 181-185. doi:10.1259/0007-1285-67-794-181Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. (Journal article)
Doherty, D. G., Donaldson, P. T., Underhill, J. A., Farrant, J. M., Duthie, A., Mieli-Vergani, G., . . . Mowat, A. P. (1994). Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis.. Hepatology (Baltimore, Md.), 19(3), 609-615. doi:10.1002/hep.1840190311Cerebrovascular event following taxol infusion. (Journal article)
Chan, A. T., Leung, W. T., & Johnson, P. J. (1994). Cerebrovascular event following taxol infusion.. Clinical oncology (Royal College of Radiologists (Great Britain)), 6(3), 202-203. doi:10.1016/s0936-6555(94)80062-6Community prevalence of hepatitis C viraemia: a polymerase chain reaction study. (Journal article)
Sallie, R., King, R., Silva, E., Tibbs, C., Johnson, P., & Williams, R. (1994). Community prevalence of hepatitis C viraemia: a polymerase chain reaction study.. Journal of medical virology, 43(2), 111-114. doi:10.1002/jmv.1890430202Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma. (Journal article)
Leung, T. W., Lau, W. Y., Ho, S. K., Chan, M., Leung, N. W., Lin, J., . . . Li, A. K. (1994). Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma.. Cancer chemotherapy and pharmacology, 33 Suppl, S33-S36. doi:10.1007/bf00686665Hazards of interferon treatment in patients with autoimmune chronic active hepatitis. (Journal article)
Farhat, B. A., Johnson, P. J., & Williams, R. (1994). Hazards of interferon treatment in patients with autoimmune chronic active hepatitis.. Journal of hepatology, 20(4), 560-561. doi:10.1016/s0168-8278(05)80507-0Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin. (Journal article)
Leung, W. T., Lau, W. Y., Ho, S. K., Chan, M., Leung, N. W., Lin, J., . . . Li, A. K. (1994). Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 35(1), 70-73.Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning. (Journal article)
Yu, K. H., Teo, P. M., Lee, W. Y., Leung, S. F., Choi, P. H., & Johnson, P. J. (1994). Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning.. Clinical oncology (Royal College of Radiologists (Great Britain)), 6(3), 167-171. doi:10.1016/s0936-6555(94)80056-1Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma. (Journal article)
Leung, W. T., Lau, W. Y., Ho, S., Chan, M., Leung, N., Lin, J., . . . Li, A. K. (1994). Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 35(8), 1313-1318.Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma. (Journal article)
Lei, K. I., Leung, W. T., & Johnson, P. J. (1994). Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.. British journal of cancer, 70(5), 1009-1013. doi:10.1038/bjc.1994.439Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. (Journal article)
Lau, W. Y., Leung, W. T., Ho, S., Leung, N. W., Chan, M., Lin, J., . . . Li, A. K. (1994). Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.. British journal of cancer, 70(5), 994-999. doi:10.1038/bjc.1994.4361993
Absence of hepatitis C virus in British patients with type 1 autoimmune chronic active hepatitis--a polymerase chain reaction and serological study. (Journal article)
Silva, E., Sallie, R., Tibbs, C., McFarlane, I., Johnson, P., & Williams, R. (1993). Absence of hepatitis C virus in British patients with type 1 autoimmune chronic active hepatitis--a polymerase chain reaction and serological study.. Journal of hepatology, 19(2), 211-215. doi:10.1016/s0168-8278(05)80573-2Gene expression regulation for interferon-alpha in hepatocellular carcinoma. (Journal article)
d'Arville, C. N., Nouri-Aria, K. T., Johnson, P., & Williams, R. (1993). Gene expression regulation for interferon-alpha in hepatocellular carcinoma.. Journal of hepatology, 17(3), 339-346. doi:10.1016/s0168-8278(05)80215-6Hepatitis viruses, cirrhosis, and liver cancer. (Journal article)
Johnson, P. J. (1993). Hepatitis viruses, cirrhosis, and liver cancer.. Journal of surgical oncology. Supplement, 3, 28-33. doi:10.1002/jso.2930530509Meeting report: International Autoimmune Hepatitis Group. (Journal article)
Johnson, P. J., & McFarlane, I. G. (1993). Meeting report: International Autoimmune Hepatitis Group.. Hepatology (Baltimore, Md.), 18(4), 998-1005. doi:10.1002/hep.18401804351992
Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters. (Journal article)
Johnson, P. J., Dobbs, N., Kalayci, C., Aldous, M. C., Harper, P., Metivier, E. M., & Williams, R. (1992). Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters.. British journal of cancer, 65(5), 751-755. doi:10.1038/bjc.1992.158Liver transplantation in carriers of the HBsAg: role of short-term passive prophylaxis with immunoglobulin. (Journal article)
Johnson, P. J. (1992). Liver transplantation in carriers of the HBsAg: role of short-term passive prophylaxis with immunoglobulin.. Journal of hepatology, 14(2-3), 411. doi:10.1016/0168-8278(92)90198-x[Hilar and peripheral cholangiocarcinomas: clinical, etiologic and molecular characteristics]. (Journal article)
Paraf, F. (1992). [Hilar and peripheral cholangiocarcinomas: clinical, etiologic and molecular characteristics].. Gastroenterologie clinique et biologique, 16(10), 822-824.1991
Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. (Journal article)
Altaee, M. Y., Johnson, P. J., Farrant, J. M., & Williams, R. (1991). Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma.. Cancer, 68(9), 2051-2055. doi:3.0.co;2-m">10.1002/1097-0142(19911101)68:9<2051::aid-cncr2820680934>3.0.co;2-mDOI: 10.1002/1097-0142(19911101)68:9<2051::aid-cncr2820680934>3.0.co;2-m
Advances in neoplastic disease of the liver and biliary tract. (Journal article)
Johnson, P. J., Wilkinson, M. L., & Karani, J. (1991). Advances in neoplastic disease of the liver and biliary tract.. Gut, Suppl, S104-S110. doi:10.1136/gut.32.suppl.s104Chronic active hepatitis. (Journal article)
Johnson, P. J., & McFarlane, I. G. (1991). Chronic active hepatitis.. Gut, Suppl, S63-S72. doi:10.1136/gut.32.suppl.s63Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma. (Journal article)
Hutchinson, W. L., Johnson, P. J., Du, M. Q., & Williams, R. (1991). Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.. Clinical science (London, England : 1979), 81(2), 177-182. doi:10.1042/cs0810177A comparison of levels of glutathione transferases, cytochromes P450 and acetyltransferases in human livers. (Journal article)
Ketterer, B., Meyer, D. J., Lalor, E., Johnson, P., Guengerich, F. P., Distlerath, L. M., . . . Yamazoe, Y. (1991). A comparison of levels of glutathione transferases, cytochromes P450 and acetyltransferases in human livers.. Biochemical pharmacology, 41(4), 635-638. doi:10.1016/0006-2952(91)90639-mDifferential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels. (Journal article)
Du, M. Q., Hutchinson, W. L., Johnson, P. J., & Williams, R. (1991). Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.. Cancer, 67(2), 476-480. doi:3.0.co;2-8">10.1002/1097-0142(19910115)67:2<476::aid-cncr2820670226>3.0.co;2-8DOI: 10.1002/1097-0142(19910115)67:2<476::aid-cncr2820670226>3.0.co;2-8
Complications (Journal article)
Johnson, P. J. (1991). Complications. Current Opinion in Gastroenterology, 7(3), 401-409. doi:10.1097/00001574-199106000-00011Epidemiology of hepatocellular carcinoma in the West. (Journal article)
Johnson, P. J. (1992). Epidemiology of hepatocellular carcinoma in the West.. Pathologie-biologie, 39(9), 896-897.Excellent prognosis in Wilsonian chronic active hepatitis: new data or an article of faith? (Journal article)
Johnson, P. J., & Williams, R. (1991). Excellent prognosis in Wilsonian chronic active hepatitis: new data or an article of faith?. Hepatology (Baltimore, Md.), 14(6), 1293-1295. doi:10.1002/hep.1840140654Frequency of asymptomatic hepatitis types B and C in an inner city community and relation to possible risk factors. (Journal article)
King, R., Johnson, P. J., White, Y. S., Smith, H. M., & Williams, R. (1991). Frequency of asymptomatic hepatitis types B and C in an inner city community and relation to possible risk factors.. The Quarterly journal of medicine, 80(292), 641-649.Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. (Journal article)
Hutchinson, W. L., Du, M. Q., Johnson, P. J., & Williams, R. (1991). Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis.. Hepatology (Baltimore, Md.), 13(4), 683-688. doi:10.1002/hep.1840130412Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. (Journal article)
Kalayci, C., Johnson, P. J., Davies, S. E., & Williams, R. (1991). Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver.. Journal of hepatology, 12(1), 54-59. doi:10.1016/0168-8278(91)90909-uImpaired binding properties of thyroxine-binding globulin in hepatocellular carcinoma and chronic liver disease. (Journal article)
Hutchinson, W. L., White, Y. S., Fagan, E. A., Johnson, P. J., & Williams, R. (1991). Impaired binding properties of thyroxine-binding globulin in hepatocellular carcinoma and chronic liver disease.. Hepatology (Baltimore, Md.), 14(1), 116-120. doi:10.1002/hep.1840140119Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol. (Journal article)
Johnson, P. J., Kalayci, C., Dobbs, N., Raby, N., Metivier, E. M., Summers, L., . . . Williams, R. (1991). Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol.. Journal of hepatology, 13(1), 120-127. doi:10.1016/0168-8278(91)90873-aRegulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma. (Journal article)
d'Arville, C. N., Nouri-Aria, K. T., Johnson, P., & Williams, R. (1991). Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.. Hepatology (Baltimore, Md.), 13(2), 310-315. doi:10.1002/hep.1840130217Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. (Journal article)
Donaldson, P. T., Doherty, D. G., Hayllar, K. M., McFarlane, I. G., Johnson, P. J., & Williams, R. (1991). Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.. Hepatology (Baltimore, Md.), 13(4), 701-706. doi:10.1002/hep.1840130415The natural course and heterogeneity of autoimmune-type chronic active hepatitis. (Journal article)
Johnson, P. J., McFarlane, I. G., & Eddleston, A. L. (1991). The natural course and heterogeneity of autoimmune-type chronic active hepatitis.. Seminars in liver disease, 11(3), 187-196. doi:10.1055/s-2008-10404361990
Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma--an overview. (Journal article)
d'Arville, C. N., & Johnson, P. J. (1990). Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma--an overview.. The Journal of steroid biochemistry and molecular biology, 37(6), 1007-1012. doi:10.1016/0960-0760(90)90458-wResponce (Journal article)
JOHNSON, P. J., & WILLIAMS, R. (1990). Responce. JNCI: Journal of the National Cancer Institute, 82(22), 1784-1785. doi:10.1093/jnci/82.22.1784-aHepatitis C antibodies and hepatocellular carcinoma: new clues or a false trail? (Journal article)
Johnson, P. J., & Williams, R. (1990). Hepatitis C antibodies and hepatocellular carcinoma: new clues or a false trail?. Journal of the National Cancer Institute, 82(12), 986-987. doi:10.1093/jnci/82.12.986Altered plasma and tissue fucosyltransferase activities in hepatocellular carcinoma. (Conference Paper)
Du, M. Q., Hutchinson, W. L., Johnson, P. J., & Williams, R. (1990). Altered plasma and tissue fucosyltransferase activities in hepatocellular carcinoma.. In Biochemical Society transactions Vol. 18 (pp. 489). doi:10.1042/bst0180489Differential binding of serum glycoproteins to lectins during hepatic regeneration in hepatocellular carcinoma and fulminant hepatic failure. (Journal article)
Du, M. Q., Hutchinson, W. L., Johnson, P. J., & Williams, R. (1990). Differential binding of serum glycoproteins to lectins during hepatic regeneration in hepatocellular carcinoma and fulminant hepatic failure.. Clinical science (London, England : 1979), 78(6), 551-555. doi:10.1042/cs0780551Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas. (Journal article)
Zaman, S. N., Johnson, P. J., & Williams, R. (1990). Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas.. Cancer, 65(7), 1607-1610. doi:3.0.co;2-2">10.1002/1097-0142(19900401)65:7<1607::aid-cncr2820650726>3.0.co;2-2DOI: 10.1002/1097-0142(19900401)65:7<1607::aid-cncr2820650726>3.0.co;2-2
Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? (Journal article)
McFarlane, I. G., Smith, H. M., Johnson, P. J., Bray, G. P., Vergani, D., & Williams, R. (1990). Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?. Lancet (London, England), 335(8692), 754-757. doi:10.1016/0140-6736(90)90870-bAuto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies. (Journal article)
Johnson, P. J., McFarlane, I. G., McFarlane, B. M., & Williams, R. (1990). Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies.. Journal of gastroenterology and hepatology, 5(3), 244-251. doi:10.1111/j.1440-1746.1990.tb01624.xFrequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers. (Journal article)
White, Y. S., Johnson, P. J., Davison, F., & Williams, R. (1990). Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.. British journal of cancer, 61(6), 909-912. doi:10.1038/bjc.1990.203Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin. (Journal article)
Kalayci, C., Johnson, P. J., Raby, N., Metivier, E. M., & Williams, R. (1990). Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin.. Journal of hepatology, 11(3), 349-353. doi:10.1016/0168-8278(90)90220-l1989
Serum α-fetoprotein and thyroxine-binding globulin in hepatocellular carcinoma (Journal article)
DU, M. -Q., HUTCHINSON, W. L., JOHNSON, P. J., & WILLIAMS, R. (1989). Serum α-fetoprotein and thyroxine-binding globulin in hepatocellular carcinoma. Biochemical Society Transactions, 17(1), 135-136. doi:10.1042/bst0170135A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma. (Journal article)
Keating, J. J., Johnson, P. J., Cochrane, A. M., Gazzard, B. G., Krasner, N., Smith, P. M., . . . Williams, R. (1989). A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.. British journal of cancer, 60(5), 789-792. doi:10.1038/bjc.1989.361Differential hormone-binding characteristics of thyroxine-binding globulin in hepatocellular carcinoma and cirrhosis. (Journal article)
Hutchinson, W. L., Johnson, P. J., White, Y. S., & Williams, R. (1989). Differential hormone-binding characteristics of thyroxine-binding globulin in hepatocellular carcinoma and cirrhosis.. Journal of hepatology, 9(2), 265-271. doi:10.1016/0168-8278(89)90062-7Role of the standard 'liver function tests' in current clinical practice. (Journal article)
Johnson, P. J. (1989). Role of the standard 'liver function tests' in current clinical practice.. Annals of clinical biochemistry, 26 ( Pt 6), 463-471. doi:10.1177/0004563289026006011988
Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression. (Journal article)
O'Grady, J. G., Johnson, P. J., Zaman, S., Calne, R. Y., & Williams, R. (1988). Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression.. Transplantation proceedings, 20(3 Suppl 3), 394-396.Hyperthyroxinaemia in hepatocellular carcinoma: relation to thyroid binding globulin in the clinical and preclinical stages of the disease. (Journal article)
Alexopoulos, A., Hutchinson, W., Bari, A., Keating, J. J., Johnson, P. J., & Williams, R. (1988). Hyperthyroxinaemia in hepatocellular carcinoma: relation to thyroid binding globulin in the clinical and preclinical stages of the disease.. British journal of cancer, 57(3), 313-316. doi:10.1038/bjc.1988.69Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. (Journal article)
Stellon, A. J., Keating, J. J., Johnson, P. J., McFarlane, I. G., & Williams, R. (1988). Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal.. Hepatology (Baltimore, Md.), 8(4), 781-784. doi:10.1002/hep.18400804141987
The separation of glutathione transferase subunits by using reverse-phase high-pressure liquid chromatography. (Journal article)
Ostlund Farrants, A. K., Meyer, D. J., Coles, B., Southan, C., Aitken, A., Johnson, P. J., & Ketterer, B. (1987). The separation of glutathione transferase subunits by using reverse-phase high-pressure liquid chromatography.. The Biochemical journal, 245(2), 423-428. doi:10.1042/bj2450423Hepatic sarcomas in adults: a review of 25 cases. (Journal article)
Forbes, A., Portmann, B., Johnson, P., & Williams, R. (1987). Hepatic sarcomas in adults: a review of 25 cases.. Gut, 28(6), 668-674. doi:10.1136/gut.28.6.668A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. (Journal article)
Warnes, T. W., Smith, A., Lee, F. I., Haboubi, N. Y., Johnson, P. J., & Hunt, L. (1987). A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report.. Journal of hepatology, 5(1), 1-7. doi:10.1016/s0168-8278(87)80053-3Another treatment for primary biliary cirrhosis. (Journal article)
Warnes, T. W., Smith, A., Johnson, P. J., Haboubi, N. Y., Babbs, C., & Lee, F. I. (1987). Another treatment for primary biliary cirrhosis.. Gastroenterology, 93(3), 664-665. doi:10.1016/0016-5085(87)90945-0Cirrhosis and the aetiology of hepatocellular carcinoma. (Journal article)
Johnson, P. J., & Williams, R. (1987). Cirrhosis and the aetiology of hepatocellular carcinoma.. Journal of hepatology, 4(1), 140-147. doi:10.1016/s0168-8278(87)80021-1Controlled clinical trial of doxorubicin and tamoxifen versus doxorubicin alone in hepatocellular carcinoma. (Journal article)
Melia, W. M., Johnson, P. J., & Williams, R. (1987). Controlled clinical trial of doxorubicin and tamoxifen versus doxorubicin alone in hepatocellular carcinoma.. Cancer treatment reports, 71(12), 1213-1216.Foreword (Journal article)
Williams, R., & Johnson, P. J. (1987). Foreword. Baillière's Clinical Gastroenterology, 1(1), ix-x. doi:10.1016/0950-3528(87)90030-3Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients. (Journal article)
Keating, J. J., O'Brien, C. J., Stellon, A. J., Portmann, B. C., Johnson, R. D., Johnson, P. J., & Williams, R. (1987). Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients.. The Quarterly journal of medicine, 62(237), 59-66.Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 alpha-dihydrotestosterone. (Journal article)
Forbes, A., Wilkinson, M. L., Iqbal, M. J., Johnson, P. J., & Williams, R. (1987). Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 alpha-dihydrotestosterone.. European journal of cancer & clinical oncology, 23(11), 1659-1664. doi:10.1016/0277-5379(87)90446-9The clinical features and natural history of malignant liver tumours. (Journal article)
Johnson, P. J. (1987). The clinical features and natural history of malignant liver tumours.. Bailliere's clinical gastroenterology, 1(1), 17-34. doi:10.1016/0950-3528(87)90032-71986
Serum concentrations of sex hormone binding globulin in lung cancer. (Journal article)
Serum concentrations of sex hormone binding globulin in lung cancer. (1986). British medical journal (Clinical research ed.), 293(6556), 1238-1239. doi:10.1136/bmj.293.6556.1238Serum concentrations of sex hormone binding globulin in lung cancer. (Journal article)
Corbishley, T. P., Keating, J. J., Johnson, P. J., & Williams, R. (1986). Serum concentrations of sex hormone binding globulin in lung cancer.. British medical journal (Clinical research ed.), 293(6550), 791-792. doi:10.1136/bmj.293.6550.791Vitamin B6 concentrations in patients with chronic liver disease and hepatocellular carcinoma. (Journal article)
Zaman, S. N., Tredger, J. M., Johnson, P. J., & Williams, R. (1986). Vitamin B6 concentrations in patients with chronic liver disease and hepatocellular carcinoma.. British medical journal (Clinical research ed.), 293(6540), 175. doi:10.1136/bmj.293.6540.175Hepatocellular carcinoma in immigrants to the United Kingdom. (Journal article)
Zaman, S. N., Johnson, P. J., & Williams, R. (1986). Hepatocellular carcinoma in immigrants to the United Kingdom.. The Quarterly journal of medicine, 60(232), 813-817.Irish endocrine society (Journal article)
Cooper, T. K., Traub, A. I., Magennis, S. D., Nevin, N. C., Darzi, A., Kelly, C. J., . . . Johnson, A. (1986). Irish endocrine society. Irish Journal of Medical Science, 155(9), 335-342. doi:10.1007/bf02960713Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin. (Journal article)
Johnson, P. J., Alexopoulos, A., Johnson, R. D., & Williams, R. (1986). Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin.. Journal of hepatology, 3(2), 149-153. doi:10.1016/s0168-8278(86)80020-4Tumour markers in the diagnosis and management of patients with hepatocellular carcinoma. (Journal article)
Johnson, P. J. (1986). Tumour markers in the diagnosis and management of patients with hepatocellular carcinoma.. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 100, 68-72. doi:10.1007/978-3-642-82635-1_81985
Clinical course of cirrhosis in young adults and therapeutic potential of liver transplantation. (Journal article)
Keating, J. J., Johnson, R. D., Johnson, P. J., & Williams, R. (1985). Clinical course of cirrhosis in young adults and therapeutic potential of liver transplantation.. Gut, 26(12), 1359-1363. doi:10.1136/gut.26.12.1359Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. (Journal article)
Zaman, S. N., Melia, W. M., Johnson, R. D., Portmann, B. C., Johnson, P. J., & Williams, R. (1985). Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.. Lancet (London, England), 1(8442), 1357-1360. doi:10.1016/s0140-6736(85)91785-4Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study. (Journal article)
Dunk, A. A., Scott, S. C., Johnson, P. J., Melia, W., Lok, A. S., Murray-Lyon, I., . . . Thomas, H. C. (1985). Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study.. Journal of hepatology, 1(4), 395-404. doi:10.1016/s0168-8278(85)80777-7Recombinant human gamma-interferon in primary hepatocellular carcinoma. (Journal article)
Forbes, A., Johnson, P. J., & Williams, R. (1985). Recombinant human gamma-interferon in primary hepatocellular carcinoma.. Journal of the Royal Society of Medicine, 78(10), 826-829. doi:10.1177/0141076885078010071984
Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma. (Journal article)
Zaman, S., Melia, W., Johnson, P., White, Y., & Williams, R. (1984). Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma.. Clinical oncology, 10(3), 247-252.Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. (Journal article)
Melia, W. M., Wilkinson, M. L., Portmann, B. C., Johnson, P. J., & Williams, R. (1984). Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.. The Quarterly journal of medicine, 53(211), 391-400.Sex hormones and the liver. (Journal article)
Johnson, P. J. (1984). Sex hormones and the liver.. Clinical science (London, England : 1979), 66(4), 369-376. doi:10.1042/cs0660369Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation. (Journal article)
Melia, W. M., Johnson, P. J., Neuberger, J., Zaman, S., Portmann, B. C., & Williams, R. (1984). Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.. Gastroenterology, 87(3), 660-663. doi:10.1016/0016-5085(84)90540-7Progesterone receptors in malignant and foetal pancreatic tissue (Journal article)
Corbishley, T. P., Iqbal, M. J., Johnson, P. J., & Williams, R. (1984). Progesterone receptors in malignant and foetal pancreatic tissue. IRCS Medical Science, 12(7), 575-576.Ultrasound determination of liver size and assessment of patients with malignant liver disease. (Journal article)
Raeth, U., Johnson, P. J., & Williams, R. (1984). Ultrasound determination of liver size and assessment of patients with malignant liver disease.. Liver, 4(5), 287-293. doi:10.1111/j.1600-0676.1984.tb00940.x1983
Sex-steroid enzymes, aromatase and 5 alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue. (Journal article)
Iqbal, M. J., Greenway, B., Wilkinson, M. L., Johnson, P. J., & Williams, R. (1983). Sex-steroid enzymes, aromatase and 5 alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue.. Clinical science (London, England : 1979), 65(1), 71-75. doi:10.1042/cs0650071Serum ferritin in hepatocellular carcinoma. A comparison with alphafetoprotein. (Journal article)
Melia, W. M., Bullock, S., Johnson, P. J., & Williams, R. (1983). Serum ferritin in hepatocellular carcinoma. A comparison with alphafetoprotein.. Cancer, 51(11), 2112-2115. doi:3.0.co;2-6">10.1002/1097-0142(19830601)51:11<2112::aid-cncr2820511126>3.0.co;2-6DOI: 10.1002/1097-0142(19830601)51:11<2112::aid-cncr2820511126>3.0.co;2-6
Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin. (Journal article)
Melia, W. M., Johnson, P. J., & Williams, R. (1983). Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin.. Cancer, 51(2), 206-210. doi:3.0.co;2-p">10.1002/1097-0142(19830115)51:2<206::aid-cncr2820510206>3.0.co;2-pDOI: 10.1002/1097-0142(19830115)51:2<206::aid-cncr2820510206>3.0.co;2-p
Low serum testosterone concentrations in patients with carcinoma of the pancreas. (Journal article)
Greenway, B., Iqbal, M. J., Johnson, P. J., & Williams, R. (1983). Low serum testosterone concentrations in patients with carcinoma of the pancreas.. British medical journal (Clinical research ed.), 286(6359), 93-95. doi:10.1136/bmj.286.6359.93Sex steroid receptor proteins in foetal, adult and malignant human liver tissue. (Journal article)
Iqbal, M. J., Wilkinson, M. L., Johnson, P. J., & Williams, R. (1983). Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.. British journal of cancer, 48(6), 791-796. doi:10.1038/bjc.1983.268[Sonographic diagnosis in primary cancer of the liver]. (Journal article)
Räth, U., Johnson, P. J., & Williams, R. (1983). [Sonographic diagnosis in primary cancer of the liver].. Der Radiologe, 23(3), 108-113.1982
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. (Journal article)
Paradinas, F. J., Melia, W. M., Wilkinson, M. L., Portmann, B., Johnson, P. J., Murray-Lyon, I. M., & Williams, R. (1982). High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.. British medical journal (Clinical research ed.), 285(6345), 840-842. doi:10.1136/bmj.285.6345.840Serum ribonuclease in the diagnosis of pancreatic carcinoma and in monitoring chemotherapy. (Journal article)
Corbishley, T. P., Greenway, B., Johnson, P. J., & Williams, R. (1982). Serum ribonuclease in the diagnosis of pancreatic carcinoma and in monitoring chemotherapy.. Clinica chimica acta; international journal of clinical chemistry, 124(2), 225-233. doi:10.1016/0009-8981(82)90390-4Oestrogen and Androgen Receptor Proteins in Malignant, Normal, and Foetal Liver in Man (Journal article)
Wilkinson, M. L., Iqbal, M. J., Johnson, P. J., & Williams, R. (1982). Oestrogen and Androgen Receptor Proteins in Malignant, Normal, and Foetal Liver in Man. Clinical Science, 63(3), 65P. doi:10.1042/cs063065paOf woodchucks and men: the continuing story of hepatitis B and hepatocellular carcinoma. (Journal article)
Johnson, P. J., & Williams, R. (1982). Of woodchucks and men: the continuing story of hepatitis B and hepatocellular carcinoma.. British medical journal (Clinical research ed.), 284(6329), 1586-1588. doi:10.1136/bmj.284.6329.1586Pancreatic carcinoma - a sex-steroid responsive tumour? (Journal article)
Greenway, B. A., Iqbal, M. J., Johnson, P. J., & Williams, R. (1982). Pancreatic carcinoma - a sex-steroid responsive tumour?. Proceedings of the American Society of Clinical Oncology, Vol. 1.Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome. (Journal article)
Melia, W. M., Nunnerley, H. B., Johnson, P. J., & Williams, R. (1982). Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.. British journal of cancer, 46(3), 331-339. doi:10.1038/bjc.1982.2081981
Oestrogen receptor proteins in malignant and fetal pancreas. (Journal article)
Greenway, B., Iqbal, M. J., Johnson, P. J., & Williams, R. (1981). Oestrogen receptor proteins in malignant and fetal pancreas.. British medical journal (Clinical research ed.), 283(6294), 751-753. doi:10.1136/bmj.283.6294.751Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma. (Journal article)
Melia, W. M., Johnson, P. J., Carter, S., Munro-Neville, A., & Williams, R. (1981). Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma.. Cancer, 48(4), 1004-1008. doi:3.0.co;2-d">10.1002/1097-0142(19810815)48:4<1004::aid-cncr2820480425>3.0.co;2-dDOI: 10.1002/1097-0142(19810815)48:4<1004::aid-cncr2820480425>3.0.co;2-d